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Chapter 1 
General Introduction 
Plants contain various types of active components, some of which have enzyme 
inhibitory activity. The carbohydrate digestive enzyme, α-glucosidase, is the key enzyme 
located in the brush border surface membrane of intestinal cells, which catalyzes the final 
step in the process of carbohydrate digestion. α-Glucosidase inhibitors reduce blood 
glucose level by delaying the digestion of carbohydrates by the enzyme and can thus be 
used to control diabetes. 
1.1 Diabetes 
Diabetes is a common chronic metabolic disease, characterized by high blood 
sugar level that results in various health complications, including heart disease, kidney 
disease, retinopathy, and neuropathy. The prevalence of diabetes is increasing worldwide, 
and higher prevalence rates of this disease have been observed in Western Pacific and 
Southeast Asia; the number of diabetes patients in 2013 was 138 million in the Western 
Pacific and 72 million in Southeast Asia (Table 1.1), and the overall diabetes population 
Table 1.1 Regional estimates of diabetes rates by 2013 and 2035 (people aged 20 – 
79) (IDF, 2013). 
Region of 
IDF 
2013 2035 Increase in 
rate of 
diabetes 
(%) 
Population 
(million) 
People with 
diabetes 
(million) 
Population 
(million) 
People with 
diabetes 
(million) 
Africa 407.9 19.8 775.5 41.5 109.6 
Europe 658.7 56.3 668.7 68.9 22.4 
Middle East 
and North 
Africa 
374.5 34.6 583.7 67.9 96.2 
North 
America and 
Caribbean 
334.9 36.8 404.5 50.4 37.3 
South and 
Central 
America 
300.5 24.1 394.2 38.5 59.8 
Southeast 
Asia 883.2 72.1 1216.9 123.0 70.6 
Western 
Pacific 1613.2 138.2 1818.2 201.8 46.0 
World 4572.9 381.8 5861.9 591.9 55.0 
 
2 
 
was 382 million worldwide (Table 1.1). The numbers of patients with diabetes are higher 
in developed countries than developing countries.  
By 2035, the total numbers of people with diabetes have been projected to rise 
to 201 million in Western Pacific and 123 million in Southeast Asia (Table 1.1), and to 
591.9 million worldwide (Table 1.1). Fifty-five percent of the worldwide population with 
diabetes live in Southeast Asia and Western Pacific region. Bangladesh was selected for 
this study as it is located in Southeast Asia where the size of the diabetic population is 
high. 
1.2 Prevalence of diabetes in Bangladesh  
Figure 1.1 shows the prevalence of diabetes in adults according to age (IDF, 
2015). The dotted line indicates the worldwide prevalence of diabetes, while the black 
and red lines indicate the prevalence rates of diabetes in Southeast Asia and in Bangladesh, 
respectively. The ratio of diabetes is increasing among people over 50 years old in 
Bangladesh (IDF, 2015) (Fig. 1.1). One reason for this increase is rapid economic growth. 
Bangladesh had the second most rapidly growing economy in 2015, with gross domestic 
product (GDP) of 6.51% (http://www.tradingeconomics.com/bangladesh/gdp-growth). 
This is accompanied by changes in both diet and lifestyle, and therefore countermeasures 
against diabetes are required.  
 
Fig. 1.1 Prevalence of diabetes in adults by age in Bangladesh, 2015 
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1.3 Medicinal plants in Bangladesh 
The use of traditional medicinal plants is very common in Bangladesh, and its 
geographic location is suitable for growing various medicinal plant species. Table 1.2 
shows the 28 most widely used medicinal plant species from the medicinal plant database 
of Bangladesh (Metabolomics JP: www.metabolomics.jp). These data were collected 
from local people and traditional practitioners by Prof. Rahmatullah. The different parts 
of these plants were used to treat the different disease (Table 1.2). Some plant parts were 
mixed with other plant parts and used to treat a particular disease (Table 1.2). 
Table 1.2 Traditional medicinal plants in Bangladesh (Information collected by Prof. 
Rahmatullah, University of Development Alternative, Bangladesh) 
Scientific name Local name Parts used 
Communicable 
diseases 
Non-communicable 
diseases 
Abelmoschus 
moschatus 
Kalo 
kasturi  
Paste of leaves is applied   Lesions, itches, 
erectile dysfunction 
Abrus 
precatorius 
 
Sona 
kuchi 
The roots and stems of Abrus 
precatorius are crushed with leaves of 
Tinospora cordifolia, made into a paste, 
slightly warmed, and ingested. 
Tuberculosis Throat pain 
Acacia arabica Babla  Flower buds of Hibiscus rosa sinensis, 
aerial roots of Ficus benghalensis, one 
clove, and gum from Acacia arabica are 
blended together and ingested with a 
small amount of ginger juice.  
 Puerperal fever 
Acorus calamus  Boch  The rhizome of young plants is made 
into a paste, which is then applied 
externally. 
Diarrhea, coughs  Gastrointestinal 
disorders  
Alocasia 
macrorrhizos 
Man 
kachu  
Whole plant   Arsenic antidote  
Bambusa 
multiplex 
Tirwa  Ten drops of leaf juice are taken for 
fever. Leaf and root paste is applied to 
abscesses.  
 Fever, abscess, itches 
 
Bryophyllum 
calycinum  
Pathar 
kuchi  
Juice from the leaves is used.  Stomach pains,  
urination  
Cajanus cajan  Arhal Leaf juice is taken with molasses twice 
daily for seven days. 
 Jaundice 
Datura metel  
 
Dhutura  
 
Juice of the leaves is used.  
 
Coughs and 
dysentery 
 
Emblica 
officinalis 
 
Amloki  
 
Unripe fruits are chewed for strong 
teeth; paste of fruits is applied to hair to 
keep it healthy.  
Fruits powder of E. officinalis, T. 
bellirica, and T. chebula are taken in 
equal proportions and mixed with 
honey to treat long-term fever and loss 
of appetite 
 Teeth and hair 
problem, long-term 
fever, loss of 
appetite 
Eclipta alba Kesharaj  Leaf  Liver disorders 
Glinus lotoides  
 
Deema  
 
Leaves and branches washed followed 
by crushing on a shil-nora to extract 
juice. The juice is filtered and ingested. 
 Brain cancer, high 
cholesterol 
 
Gnaphalium 
luteoalbum 
Natham The plant is crushed along with dried 
fish and applied as a poultice to heal 
fractured bones. It has to be kept for 3 – 
4 days, frequently wetting with water. 
 Bone fractures 
 
4 
 
The medicinal plant database of Bangladesh includes 259 genera, some of 
which contain only a single species, others contain two species, and some contain three 
or more species. The different plant species belonging to a given genus may be used to 
treat the same or different diseases. Therefore, the total number of plant species included 
in the database is more than 259. In some cases, a similar plant was used to treat various 
diseases in different villages. The largest number of plant species were used to treat 
gastrointestinal diseases, with a total of 94 species used for these purposes (Table 1.3). 
Respiratory problems were treated with 65 species, skin diseases with 63 species, urinary 
Table 1.2 (continued) 
Scientific name Local name Parts used 
Communicable 
diseases 
Non-communicable 
diseases 
Ixora parviflora Hokhu-
chutri 
Root, stem, and leaf are boiled in water 
and bath, powder is applied to the 
affected area 
Scabies, leprosy, 
eczema 
 
Hibiscus 
vitifolius 
 
Bon 
karpas  
Juice from the roots 
 
 Kidney dysfunction 
Hoya parasitica Dupui-tha Fruits are either taken with vegetables or 
dried, powdered, and 2 – 3 pinches of 
the powder are taken. Note: higher dose 
will results in diarrhea. 
 Constipation 
Jatropha curcas Jamalgota Seed, root  Lesions Colic pain 
Justicia 
gendarussa 
Jagat 
madan  
Leaves are burned and the ashes applied 
to the affected areas. 
Scabies, eczema, 
allergy 
 
Lasia spinosa Joka The woody root of the plant is eaten 
daily for 1 week to reduce joint pain and 
edema. The leaf juice is taken to increase 
mother’s milk.  
 Joint pain, edema 
vvvLeea indica Chila-
khor 
Leaf, root  Chronic dysentery 
Madhuca indica Moa The fruits are boiled with unripe gram 
and sugar added until the decoction takes 
on a blood red color. 
 Debility, blood 
purifier 
Maesa sp. Allram  Root paste is applied   Urinary problems 
Maranta 
arundinacea 
Ararut Root  Spleen disorder 
Ocimum sanctum Kalo 
tulshi 
Juice from the leaves Common cold Malaria 
Plumbago indica Agnichita Leaf  Ophthalmia 
Sida cordifolia Berela Leaf juice is taken once every morning 
for a month as a remedy for nerve 
weakness. Bark of the root is powdered 
and one teaspoon of powder taken with 
15 – 20 ml of cold water daily. 
 Nerve weakness,  
Urinary problems 
Terminalia 
bellirica  
 
Bohera Inner parts of fruits are taken for 
diarrhea; dried pulp is taken for cough 
relief. 
Fruits of E. officinalis, T. bellirica, and 
T. chebula are soaked in water and the 
water drunk every morning for 
gastrointestinal disorder. 
Diarrhea, cough 
 
Gastrointestinal 
disorder 
Terminalia 
chebula 
Haritaki Paste of fruits and roots is taken twice a 
day 
Cough Asthma 
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problems with 35 species, sexual diseases with 31 species, fever with 28 species, liver 
disease with 22 species, and diabetes with 18 species. Twenty-seven species were used 
for treating other diseases (edema, body pain, cancer, tumor, eye problems, blood-related 
diseases, dental problems, ulcers, insomnia, narcotic, menstrual disorders, cardiovascular 
disease, nervous system disorders, and weakness) (Table 1.3). Although many medicinal 
plants are using to treat various types of disease in Bangladesh, very few plant species are 
used to control diabetes in this country (Table 1.3). The most widely used medicinal 
plants (28 plants) were not used for diabetes, because the number of diabetes patients in 
Bangladesh is still low (Table 1.2). However, the numbers of patients with diabetes are 
likely to increase because people 56 – 59 years old are developing diabetes in Bangladesh 
(Fig. 1.1). Therefore, medicinal plants were used in these experiments.  
1.4 Background and purpose 
This research had two main aspects: (1) to identify new medicinal plants from 
Bangladesh for diabetes, and (2) to identify new compounds from Japanese plant leaves 
for diabetes. Many people use traditional medicine in Bangladesh to treat various diseases. 
About 80% of rural people are dependent on traditional medicine for their primary 
healthcare, such as a coughs, colds, fevers, headaches, and dysentery (Hossain, 2005). 
For the treatment of diabetes, plants have been used in various systems of medicine from 
ancient times, especially in developing countries where large numbers of people have 
limited access to natural sources and access to allopathic treatment for diabetes (Ali et al., 
 Table 1.3 Numbers of Bangladeshi traditional medicinal plant 
species used to treat different diseases. 
 
 
Name of disease Number of plant 
species used for 
treatment 
 
 Gastrointestinal problems 94  
 Respiratory problems 65  
 Skin diseases 63  
 Urinary problems 35  
 Sexual diseases 31  
 Fever  28  
 Liver diseases 22  
 Diabetes 18  
 Others 27  
 Gastrointestinal problems 94  
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2006; Nickavar and Yousefian, 2009). Therefore, three Bangladeshi medicinal plants 
were screened for antidiabetic effects. 
Japanese people use traditional medicine occasionally, which is known as 
Kampo. In Japan, the amount of the use of traditional medicine is not large as modern 
medicine. In Japanese hospitals and clinics, modern medicine facilities were dominant 
although traditional medicine is partially practiced there (Park et al., 2012). Therefore, 
we used 19 types of Japanese woody plant leaves to investigate the inhibitory effects on 
diabetes and identify the structures of active compounds to make modern medicines. 
1.5 Antidiabetic compounds of some plants 
The digestive enzyme, α-glucosidase, breaks down carbohydrates, such as 
starch and disaccharides, to glucose. α-Glucosidase inhibitors reduce the rate of digestion 
of carbohydrates, and the carbohydrate absorption process is delayed resulting in a 
decrease in blood glucose level. 
Oki et al. (1999) reported that some natural compounds have been shown to 
have α-glucosidase activity. Among them, flavonoids are the major class of polyphenolic 
compounds, which are present in many plants and plant parts and have protective effects 
against many diseases. Flavonoids are polyphenolic compounds that play major roles in 
the treatment of diabetes (Babu et al., 2013). It has been reported that some natural 
compounds have efficacy against diabetes (Table 1.4). 
Table 1.4 Antidiabetic compounds of some plants 
Plant Plant parts Compounds Extract References 
Salacia reticulata 
 
Root, stem Sulfated kotalanol, 
Ponkolanol, Salaprinol 
Water  Muraoka et al., 
2008 
Belamcanda chinensis  
 
Leaves 
 
Daidzin and Genistein  
 
Water  Wu et al., 2012 
Ocimum sanctum Leaves Polyphenols, caffeic acid Water  Wongsa et al., 
2012 
Stevia rebaudiana Leaves Alkaloids, flavonoids Water  Kujur et al., 2010 
Curcuma longa Rhizome Curcumin, ar-turmerone Ethanolic  Kuroda et al., 2005 
Eleutherine americana Bulb  Eleutherinoside A Methanolic Ieyama et al., 2011 
Fagara tessmannii Bark Terpene Methanolic  Mbaze et al., 2007 
Psidium guajava Leaves Leteolin, Catechin  
Kaempferol 
Water Alagesan et al., 
2012 
Adhatoda vasica Nees Leaves Alkaloid Methanolic  Gao et al., 2008 
Matricaria chamomilla  Leaves Apegenin, luteolin Water  Kato et al., 2008 
Rhodiola crenulata Root Epicatechin gallate, 
epicatechin 
Water Chu et al., 2014 
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1.6 Carbohydrates 
Carbohydrates in the diet are metabolized to the monosaccharide, glucose, in 
the human body by enzymatic processes from the mouth to the small intestine. 
Uncontrolled high blood glucose level can lead to diabetes. Blood glucose level is 
affected by intake of carbohydrates, the most abundant nutrients in the diet, with an 
average percentage of 19.2%. 
Carbohydrates are classified into three major classes: monosaccharides, 
disaccharides, and polysaccharides. Glucose, fructose, and galactose are 
monosaccharides, which are absorbed directly via the small intestine. Sucrose, lactose, 
and maltose are disaccharides, which are broken down into monosaccharides for 
absorption in the small intestine by specific enzymatic activity. Starch and fiber are 
polysaccharides, among which fiber is resistant to the enzymatic action, while starch 
breaks down in the mouth by enzymatic activity.  
1.7 Carbohydrate digestive enzymes 
The most common and abundant carbohydrate ingredients in the diet are sugar 
and starch. The final step of carbohydrate digestion is the key step in regulating blood 
glucose level. The carbohydrate digestive enzyme, α-glucosidase (maltase and sucrase) 
is an enzyme that catalyzes the final step in the process of carbohydrate digestion in the 
small intestine. Delaying carbohydrate digestion and absorption through the inhibition of 
α-glucosidase activity is a useful treatment for diabetes. The inhibition of α-glucosidase 
can delay the carbohydrate digestion process in the small intestine and finally control 
postprandial hyperglycemia (Van de Laar, 2008). This approach is one of the best 
strategies for the treatment of diabetes. Therefore, two digestive enzymes, maltase and 
sucrase, were selected in this study.  
In general, carbohydrate (substrate) binds the catalytic site on the enzyme to 
form the enzyme–substrate complex. The product (glucose) is produced when the 
enzyme–substrate complexes breaks down and releases the free enzyme. Thereafter, 
glucose is absorbed via the small intestine and is circulated in the blood. α-Glucosidase 
inhibitors are needed to control high blood glucose levels. The α-glucosidase inhibitor 
binds to the active site of the enzyme, thus preventing the carbohydrate substrate binding 
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to the active site and preventing its breakdown into glucose. Consequently, the α-
glucosidase inhibitor decreases hydrolytic cleavage of carbohydrate, and thus overall 
glucose absorption is reduced and diabetes can be controlled.  
Several antidiabetic agents have been reported. Three α-glucosidase inhibitors, 
acarbose, miglitol, and voglibose, which can delay carbohydrate absorption in the small 
intestine and reduce the blood sugar level, are widely used as oral antidiabetic drugs 
(Tiwari and Rao, 2002). However, these drugs have frequent gastrointestinal side effects, 
such as flatulence, diarrhea, and stomachache (Van de laar, 2005). Therefore, there is 
interest in screening of natural products isolated from different plant extracts to find new 
natural antidiabetic agents with less side effects. 
1.8 Targeted plants  
This study focused on three plants, Emblica officinalis, Terminalia bellirica, 
and Terminalia chebula, which have been used for thousands of years in traditional 
Ayurvedic medicine to treat various types of disease in Bangladesh and India. However, 
the leaves of these three plants have not been used in traditional medicine. Therefore, this 
study examined the medicinal effects of the leaves of these three Bangladeshi medicinal 
plants (Chapter 2). These three plants are used in various ways in traditional medicine in 
Bangladesh. Pastes made from the bark and roots are applied to affected areas of the skin. 
Powder prepared from the fruits of these three plants are taken in equal proportions and 
mixed with honey to treat long-term fever and loss of appetite. Fruits of these three plants 
are soaked in water, which is then drunk every morning to treat gastrointestinal disorders. 
The traditional Ayurvedic formulation consisting of a combination of fruits of these three 
plants is called “triphala.”  
The leaves of 19 Japanese woody plants were also investigated for potential 
inhibitory effects against α-glucosidase in this study. Medical value of these plant species 
is not known in Japan. In addition, there have been no previous reports regarding in vitro 
α-glucosidase inhibitory activity of these plants. 
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1.9 Aims of dissertation  
The aims of this study are summarized as follows:  
To evaluate the antidiabetic potential of different extracts of the leaves from three 
Bangladeshi plants (Chapter 2). 
To investigate the effects of different extracts of the leaves from 19 Japanese woody 
plants (Chapter 3). 
To isolate and purify active compounds from the plant extracts that have inhibitory 
effects against α-glucosidase (Chapter 4). 
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Chapter 2 
Inhibitory effects of Bangladeshi medicinal plant leaf 
extracts on α-glucosidase activity 
Abstract 
One of the best strategies in treatment of diabetes mellitus management 
involves control of postprandial hyperglycemia through enzymatic inhibition of starch 
degradation. Emblica officinalis, Terminalia bellirica, and Terminalia chebula are used 
as remedies in Ayurvedic medicine. In this study, methanol extracts of the leaves of these 
three plant species were screened for their α-glucosidase inhibitory potential activities in 
vitro. Methanol extract of T. chebula showed maximum inhibitory activity against yeast 
α-glucosidase with a half maximal inhibitory concentration (IC50) of 15 µg/ml, followed 
by T. bellirica with IC50 value of 34 µg/ml and E. officinalis with a value of 50 µg/ml, 
compared with the standard drug, acarbose (IC50 value: 13 mg/ml). Rat intestinal sucrase 
inhibitory activity was also investigated. The methanol extracts of these three plants at 1 
mg/ml showed considerable rat intestinal sucrase inhibitory activity. The hexane extract, 
ethyl acetate extract, butanol extract, and water extract from the three plants were 
screened for yeast α-glucosidase and rat intestinal sucrase inhibitory activity. Among the 
three plants, butanol extract exhibited potent α-glucosidase inhibitory activity. Methanol 
and butanol extracts of the three plants also showed excellent inhibitory activity against 
rat intestinal sucrase. E. officinalis, T. bellirica, and T. chebula are potential plant sources 
of α-glucosidase inhibitors that can be used to treat diabetes.  
Keywords: α-glucosidase inhibitor, diabetes, Emblica officinalis, Terminalia bellirica, 
Terminalia chebula 
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2.1 Introduction 
The incidence of diabetes is increasing worldwide. Saquib et al. (2012) reported 
that the number of diabetes patients in Bangladesh has increased from 3.8% in 1995 to 
9% in 2010. The prevalence of diabetes is increasing in Bangladesh due to inadequate 
healthcare facilities in rural areas, lack of health consciousness, poor economic conditions, 
lifestyle changes caused by rapid urbanization, and changes in food habits. The Global 
Change Makers Program also indicated that the poor people in Bangladesh are suffering 
lifestyle-related diseases such as diabetes (Global Change Makers Program, 2013). 
Although the numbers of diabetic patients are rapidly increasing, 
countermeasures have not been developed in Bangladesh. There are several reasons for 
the difficulty in coping with diabetes in Bangladesh, e.g., poverty, limitations of health 
care facilities, low capability of spending on health care expenses, lack of understanding 
of health condition, lack of education, lack of information about diabetes, inadequate 
opportunities for annual health checks and lack of knowledge prevent people in this 
country from taking modern medicines. Especially, facilities for diabetes treatment are 
not available in health centers, and nurse practitioners do not have sufficient training for 
early identification of prediabetes in Bangladesh (Islam et al., 2013). 
Traditional medicines, which are commonly used in rural areas, represent one 
solution to these problems. Traditional medicine has a long history of use in Bangladesh, 
and has the advantage of reduced medical expenses. Rahman (2013) reported that large 
numbers of people use traditional medicines for various diseases, such as skin diseases, 
joint pain, diarrhea, cough, stomach problems, and diabetes. Ayurvedic traditional 
medicine has been used since ancient times in Bangladesh (Yoshida et al., 2016). 
Traditional medicine has been reported to show fewer side effects than allopathic 
medicines, and Vipula (2014) reported a good response to Ayurvedic treatment compared 
to allopathic treatment, with no side effects.  
Traditional medicinal plants are also used to provide affordable treatments for 
diabetes mellitus with advances in many herbal medicinal health care systems in 
Bangladesh. Various types of medicinal plants and plant parts are used in traditional 
medicine for diabetes. In addition to traditional practitioners reporting good responses, 
their treatments can be validated scientifically based on the antidiabetic properties of 
 
12 
 
components of their medicinal plants. Grover et al. (2002) showed that antihyperglycemic 
agents are present in various plant extracts that have been used as traditional medicine.  
In this study, we focused on three plants, Emblica officinalis, Terminalia 
bellirica, and Terminalia chebula (Fig. 2.1), which are widely distributed southern India, 
Pakistan, Bangladesh and other South-East Asian countries and have been extensively 
used in traditional medicine in Bangladesh and the Indian subcontinent. The traditional 
herbal formulation consisting of a combination of fruits of these three plants called 
“triphalaˮ is very popular in traditional Ayurvedic medicine, and has been used for 
thousands of years against various types of disease. Mukherjee et al. (2006) reported that 
“triphala and triphala mixtureˮ follows a standardized ayurvedic formula, which has been 
clinically tested and shown to exhibit good results against constipation and appetite 
problems. 
These three plants are well known as individual herbal remedies. E. officinalis 
has been reported to possess antiinflammatory (Golechha et al., 2014), antioxidant 
(Scartezzini et al., 2006), hepatoprotective (Jose et al., 2000), antipyretic and analgesic 
activities (Perianayagam et al., 2004). T. chebula has been reported to show anticancer 
(Ahuja et al., 2013), antiviral (Kim et al., 2001), antibacterial (Kannan et al., 2009), 
antioxidant (Cheng et al., 2003), and wound healing activities (Singh et al., 2009). T. 
bellirica has been studied for its antimicrobial (Devi et al., 2014), anti-HIV-1, 
antimalarial, antifungal (Valsaraj et al., 1997), analgesic, and antipyretic activities 
(Sharma et al., 2010). 
   
A. Emblica officinalis B.Terminalia chebula C. Terminilia bellirica 
Figure 2.1 Plant leaves used in this study. 
A: E. officinalis belongs to the family Euphorbiaceae. B: T. chebula belongs to the family 
Combretaceae. C: T. bellirica belongs to the family Combretaceae. 
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Moreover, Sabu and Kuttan (2002) reported that oral administration of an 
extract of E. officinalis, T. bellirica, and T. chebula fruits effectively decreased the serum 
glucose level in diabetic rats. T. chebula seed extracts showed a remarkable decrease in 
blood glucose level by increasing insulin secretion in both short and long term studies 
(Rao and Nammi, 2006). 
The therapeutic potentials of various parts of the above three plants from 
different regions have been evaluated in previous studies. However, the antidiabetic 
potential of the leaves collected from Bangladesh has not been reported. While the fruits 
and seeds of E. officinalis, T. chebula, and T. bellirica have been reported to show 
antihyperglycemic effects, there have been no studies regarding the α-glucosidase 
inhibitory activity of leaves of these three plants collected from Bangladesh. The present 
study was designed to evaluate the antidiabetic potentials of different extracts of these 
three plant leaves through monitoring of the inhibitory effects on yeast and rat intestinal 
α-glucosidase. 
α-Glucosidases, which include maltase, maltase-glucoamylase, etc., are the key 
enzymes. The α-glucosidase from the yeast, Saccharomyces cerevisiae is commonly used 
to search for biologically active compounds with inhibitory effects on the enzyme in vitro. 
Hogan et al. (2010) used yeast α-glucosidase as a model for isolation and identification 
of inhibitory substances from natural products. The p-nitrophenyl-α-D-glucopyranoside 
was used as a synthetic substrate in the assay of yeast α- glucosidase, which catalyzes 
glucose and p-nitrophenol. Yeast α-glucosidase and p-nitrophenyl-α-D-glucopyranoside 
substrates were developed for analysis of maltase inhibitory activity. Starch is the most 
important carbohydrate in the human body, and is catalyzed into maltose by α-amylase, 
which in turn is catalyzed into glucose by maltase in the brush-border surface membrane 
of the small intestine. 
Sucrose is the most commonly used sugar all over the world, and is degraded 
into glucose and fructose by the α-glucosidase, sucrase. Rat intestinal acetone powder has 
been used as a source of sucrase for in vitro assays with sucrose as the substrate. Ohta et 
al. (2002) reported that the rat intestinal acetone powder α-glucosidase closely mimics 
that in the mammalian system in vivo and may be a superior model for use in studies to 
develop methods for the control of postprandial blood glucose. Enzymes from different 
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sources catalyze different substrates. Therefore, we used two types of α-glucosidase, i.e., 
yeast α-glucosidase and rat intestinal α-glucosidase, in this study. 
Diabetes mellitus is a group of serious metabolic disorders associated with high 
blood glucose levels due to a failure of the body to produce insulin properly. At present, 
three main types of diabetes are known, i.e., type I insulin-dependent diabetes, type II 
non-insulin-dependent diabetes, and gestational diabetes (International Diabetes 
Federation, 2013). Type II has the highest prevalence rate, and the control of postprandial 
blood glucose level is important in its treatment. The inhibition of α-glucosidase is 
essential to delay carbohydrate digestion and absorption, reduce blood glucose levels, and 
finally control postprandial hyperglycemia. Acarbose, miglitol, and voglibose are well- 
known clinically approved inhibitors of α-glucosidase activity (Van de Laar, 2008). 
However, these α-glucosidase inhibitors have number of undesirable side effects, 
including gastrointestinal problems (Cheng et al., 2005). Therefore, natural α-glucosidase 
inhibitors that are safe, effective, and have no or only minor side effects are required. 
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2.2 Materials and Methods 
2.2.1 Plant collection and extraction  
The leaves of the three plant species were collected from the Bangladesh 
Agricultural University, packed in the newspaper, and dried in the sun. The dried samples 
were crushed in a blender, and then boiled in methanol at 60ºC -70ºC three times. Boiled 
leaf extracts were dried under reduced pressure using a rotary evaporator. These dried 
methanol extracts were dissolved in 30% hexane/70% methanol solution and successively 
partitioned with the same volume of hexane, ethyl acetate, butanol, and water by adding 
each solution as shown in Fig. 2.2. The solvents were again evaporated and the remaining 
substances were used as the test materials. The methanol extracts and their partitioned 
fractions were monitored for inhibitory effects on α-glucosidase activity. 
Generally, plant bioactive compounds consist of various classes of chemicals, 
such as alkaloids, glycosides, lignins, tannins, terpenoids, etc. The methanol extracts of 
the plants were used because many molecules, including fatty acids, water-soluble 
materials, and other bioactive compounds, are soluble in methanol. The major biological 
compound, bartogenic acid, was identified from the methanol extract of Barringtonia 
racemosa seed (Gowri et al., 2007). Therefore, methanol is important in screening for 
biologically active compounds, and was used in the present study.  
2.2.2 Yeast α-glucosidase inhibitory assay  
 The inhibitory activity of yeast α-glucosidase (Wako Pure Chemical Industries, 
Ltd., Osaka, Japan) was determined by the method of Babu et al. (2004) with slightly 
 
Fig. 2.2 Separation by partition scheme with several solvents. The upper layers are 
hexane, ethyl acetate, and butanol. The lower layers are water. 
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modifications. Aliquots of 20 μl of the test samples dissolved in methanol at 10 mg/ml 
were serially diluted in 96-well microtiter plates. The plant extracts diluted in10 μl of 
phosphate buffer 0.1 mol/l (pH 6.8) and 150 μl (5 mmol/ml) of p-nitrophenyl-α-D-
glucopyranoside (PNPG) were added to each well. The reaction was started by addition 
of 20 μl (5 μg/ml) of the enzyme to the reaction mixture in the 96-well plates. Individual 
blanks where the substrate was replaced with 40 μl of phosphate buffer were prepared to 
correct for background absorbance. The controls contained 20 μl of phosphate buffer in 
place of the test sample, while the leaf extract was replaced with acarbose in positive 
controls. All determinations were performed in triplicate. The changes in absorbance at 
405 nm (A405) were recorded at 1-minute intervals for 10 minutes, and the percentage 
inhibition was estimated from the slope using the following equation: 
Inhibition % = (1- slope of test sample/slope of control) ×100. 
The concentration that gave the half-maximal response (IC50) was determined 
from the sample concentration vs. percentage inhibition rate. α-Glucosidase inhibitory 
activity was expressed as inhibition % and IC50 value, with a lower IC50 value was 
indicating higher inhibitory activity. 
2.2.3 Rat intestinal α-glucosidase (sucrase) inhibitory assay 
Rat intestinal α-glucosidase inhibitory activity was determined by a 
modification of the method of Babu et al. (2004). Aliquots of 20 μl of plant extract test 
samples dissolved in methanol at 10 mg/ml were added to each well of 96-well plates. 
Then, 150 μl of 5 mg/ml saccharose was added to each well. Rat intestinal acetone powder 
(Sigma-Aldrich, St. Louis, MO) was added at 100 mg/ml to phosphate buffer 0.1 mol/l 
(pH 6.8) and sonicated for 5 minutes. The suspension was centrifuged at 2500 rpm for 5 
minutes to remove particulate matter, and the resulting supernatant was used as the 
enzyme solution. The reaction was initiated by addition of 30 μl of the enzyme to the 
reaction mixture in 96-well plates. The reaction mixture was incubated at 37ºC for 30 
minutes followed by 70ºC for 3 minutes on a heating block to stop the reaction. The 
reaction mixture was cooled to room temperature for 10 minutes and aliquots of 20 µl 
were transferred to another plate. The reaction was started by addition of 150 µl of reagent 
(Glucose C2; Wako) and cooled to 25ºC for 15 minutes. Individual blanks where the 
substrate was replaced with 50 μl of phosphate buffer were prepared to correct for 
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background absorbance. The controls contained 20 μl of phosphate buffer in place of the 
test sample, while the leaf extract was replaced with acarbose in positive controls. All 
determinations were performed in triplicate. The changes in absorbance at 492 nm (A492) 
were recorded at 1-minute. The percentage inhibition was estimated using the following 
equation: 
Inhibition % = (1 - (absorbance of test sample-absorbance of blank) / 
(absorbance of control-absorbance of blank)) ×100.  
2.2.4 Statistical analysis 
The effects of crude methanol extracts (Fig. 2.3) and fractionated extracts (Fig. 
2.4) of the leaves from three medicinal plants, E. officinalis, T. bellirica, and T. chebula 
were examined by analysis of variance (ANOVA) followed by Tukey’s multiple 
comparison tests using SPSS version 16.0 for windows (SPSS Inc., Chicago, IL). In all 
analyses, p < 0.01was taken to indicate statistical significance. 
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2.3 Results 
E. officinalis yielded the highest percentage (18%) of methanol extract from 50 
g of plant material (Table 2.1), with T. chebula and T. bellirica showing  methanol extract 
yields of 15% and 12%, respectively (Table 2.1). The methanol extracts were screened 
for their α-glucosidase inhibitory activities. The methanol extracts of the three plants 
showed significant in vitro α-glucosidase inhibitory activity compared with acarbose (13 
mg/ml), with T. chebula showing the highest inhibitory activity (IC50 = 15 µg/ml), 
followed by T. bellirica  (IC50 = 34 µg/ml), and E. officinalis (IC50 = 50 µg/ml) (Table 
2.2).  
The hexane fraction of T. chebula leaves was inactive, while the ethyl acetate, 
butanol, and water fractions showed α-glucosidase inhibitory activity. The T. chebula 
butanol fraction showed a strong inhibitory effect with an IC50 value of 10 µg/ml (Table 
2.3). The hexane fraction of E. officinalis leaf extract showed no inhibitory activity 
against α-glucosidase. The butanol and ethyl acetate fractions of E. officinalis showed 
almost the same inhibitory activities, with IC50 values of 18 µg/ml and 19 µg/ml, 
respectively (Table 2.3). The hexane fraction of T. bellirica leaves was also less active 
than the ethyl acetate, butanol, and water fractions, with IC50 values for the butanol and 
ethyl acetate fractions of 12 µg/ml and 18 µg/ml, respectively (Table 2.3). 
The inhibitory activities of the methanol extracts (12.5 µg/ml) and fractionated 
extracts (10 µg/ml) from the three plants against yeast α-glucosidase were analyzed and 
Table 2.1 Efficiency of methanol extraction from the leaves of three Bangladeshi 
medicinal plants 
Scientific Name Family name Leaf weight (gm) 
Quantity of methanol 
extract (gm) Extract rate (%) 
Emblica officinalis Euphorbiaceae 50 9 18 
Terminalia chebula Combretaceae 30 5 15 
Terminalia bellirica Combretaceae 26 3 12 
Percentage extract yield (w/w) was calculated as (dry extract weight/dry starting material weight) × 100. 
 Table 2.2 Effects of methanol extracts from the leaves of three 
medicinal plants against yeast α-glucosidase. 
 
 Plant Name IC50  µg/ml  
 Emblica officinalis 50   
 Terminalia chebula 15   
 Terminalia bellirica 34   
 Acarbose (positive control: ) 13,000  
 Acarbose was used as a positive control. 
IC50: Concentration of the antagonist that inhibited the enzyme reaction by 50%. 
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the results are shown in Figures 2.3 and 2.4, respectively. There were significant 
differences in the effects of the methanol extracts between the plant species, with that of 
T. chebula showing the maximum inhibitory effect (46%) followed by E. officinalis 
(32%) and T. bellirica (30%) (Fig. 2.3). There were no significant differences in the 
inhibitory effects of ethyl acetate extracts among the three plant species (Fig. 2.4). The 
butanol extracts of T. chebula and T. bellirica showed similar inhibitory effects (50% and 
46%, respectively), while E. officinalis showed a weaker effect (32%) (Fig. 2.4). The 
water extract of T. chebula showed the greatest inhibitory effect (50%), with E. officinalis 
and T. bellirica are showing lower inhibitory effects (21% and 23%, respectively) (Fig. 
2.4).  
Table 2.3 Inhibitory effects of fractionated extracts of three medicinal plants on yeast 
α-glucosidase activity 
Plant Name 
IC50 µg/ml 
Hexane 
extract 
Ethyl acetate 
extract 
Butanol 
extract 
Water 
extract 
Emblica officinalis NA 19  18  37  
Terminalia chebula NA 26  10  10  
Terminalia bellirica 102  18  12  33  
Acarbose (positive control) 13,000 
Acarbose was used as a positive inhibitory molecule. 
IC50: Concentration of the antagonist that inhibited the enzyme reaction by 50%. 
NA: No activity 
 
Fig. 2.3 Effects of methanol extracts of the leaves from three medicinal plants on 
yeast α-glucosidase activity (12.5 μg/ml). 
The same letters above the bars in the graph indicate that the mean did not differ significantly, 
while different letters indicate significant variation at P < 0.01.  The values are expressed as 
means ± standard deviation, n =3. 
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In this study, the inhibitory effects of leaf extracts from the three plant species 
against sucrase activity were determined and compared with that of acarbose (91%, Table 
2.4). The methanol extracts of E. officinalis, T. chebula, and T. bellirica leaves at 1 mg/ml 
 
Fig. 2.4 Inhibitory effects of fractionated extracts of the leaves from three medicinal 
plants on yeast α-glucosidase activity (10 μg/ml). 
The same letters above the bars in the graph indicate that the mean did not differ significantly, 
while different letters indicate significant variation at P < 0.01. The values are expressed as 
means ± standard deviation, n =3. 
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Table 2.4 Inhibitory effects of extracts of the leaves from three medicinal plants on 
rat intestinal sucrase and yeast α-glucosidase. 
Plant Name Extract Type 
% of rat intestinal sucrase 
inhibitory effect 
% of yeast α-glucosidase 
inhibitory effect 
1mg/ml 200 µg/ml 
Emblica officinalis Methanol 81  ± 7 95  ± 1 
Hexane 33  ± 3 22  ± 5 
Ethyl acetate 49  ± 7 95  ± 1 
Butanol 58  ± 4 98  ± 1 
Water 50  ± 2 83  ± 2 
Terminalia chebula Methanol 89 ± 4 90  ± 1 
Hexane 39  ± 11 9   ± 3 
Ethyl acetate 54  ± 10 68  ± 0 
Butanol 67  ± 14 97  ± 1 
Water 62  ± 10 94  ± 1 
Terminalia bellirica Methanol 70  ± 9 89  ± 2 
Hexane 27  ± 6 65  ± 4 
Ethyl acetate 41  ± 1 94  ± 0 
Butanol 50  ± 5 98  ± 0 
Water 38  ± 8 94  ± 1 
Acarbose (positive control)  91 ± 3 5  ± 4 
The values are expressed as means ± standard deviation, n =3. 
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in the reaction mixtures showed significant inhibitory effects against sucrase enzyme 
activity (Table 2.4), with that of T. chebula showing the greatest effect (89%). We also 
investigated the inhibitory effects of hexane, ethyl acetate, butanol, and water extracts of 
the leaves from these plants against sucrase activity. The butanol extract of E. officinalis 
and water extract of E. officinalis were shown to inhibit the enzyme activity by 58% and 
50%, respectively (Table 2.4). However, the hexane extract of E. officinalis showed only 
a weak inhibitory effect (33%) on sucrase activity, while acarbose as a positive control 
showed 91% inhibition of the enzyme activity at a concentration of 1 mg/ml (Table 2.4). 
Ethyl acetate, butanol, and water fractions of T. chebula leaves showed the 
highest sucrase inhibitory effects (54%, 67%, and 62%, respectively), and the weakest 
effect was observed for the hexane extract of T. chebula (39%, Table 2.4). The butanol 
extract of T. bellirica leaves showed an inhibitory effect of 50%, while the hexane, ethyl 
acetate, and water extracts showed lower inhibitory activities of 27%, 41%, and 38%, 
respectively (Table 2.4).   
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2.4 Discussion 
Although acarbose is a well-known antidiabetic medication, Oki et al. (1999) 
reported that acarbose did not inhibit yeast α-glucosidase activity, while it showed 
inhibitory effects on rat, rabbit, and pig small intestinal α-glucosidase activities. Kim et 
al. (2004) reported a similar result where pine bark extracts showed strong inhibitory 
effects against yeast α-glucosidase, while the standard drug, acarbose, showed no 
inhibitory effect on yeast α-glucosidase activity. These observations were compatible 
with those of the present study, in which acarbose showed only a weak inhibitory effect 
against yeast α-glucosidase with an IC50 value of 13 mg/ml, while the three plant extracts 
showed strong inhibitory effects against the activity of this enzyme (Table 2.3). In this 
study, acarbose had an IC50 value of 13 mg/ml for yeast α-glucosidase at 5 μg/ml in the 
reaction mixture, whereas Shai et al. (2011) reported that acarbose had an IC50 value of 
1.5 mg/ml for yeast α-glucosidase at 0.5 mg/ml in the reaction mixture. These results 
indicated that the different inhibitory effect of acarbose on yeast α-glucosidase, which 
may have been due to the use of different concentration of the enzyme. Shai et al. (2011) 
also mentioned that the different concentrations of the enzyme are responsible for 
different IC50 value of acarbose.  
The methanol and butanol extracts of the leaves from the three plant species, E. 
officinalis, T. bellirica, and T. chebula, showed stronger inhibitory effects against yeast 
α-glucosidase than rat intestinal sucrase (Table 2.4). At 200 μg/ml, methanol and butanol 
extracts of T. chebula inhibited yeast α-glucosidase activity by 90% and 97%, 
respectively, while at 1 mg/ml, methanol and butanol extracts of the effects of that 
inhibited on rat intestinal sucrase were lower at 89% and 67%, respectively. This result 
was supported by those of Shai et al. (2011), who found that acetone extracts of different 
plants had stronger inhibitory effects against yeast α-glucosidase than mammalian α-
glucosidase. Havsteen (1983) classified flavonoids into six groups based on the variation 
of benzopyran and phenyl groups and their ring and linkage sites, i.e., flavone, flavonol, 
flavanone, isoflavone, flavan-3-ol, and anthocyanidin. Tadera et al. (2006) reported that 
the inhibitory effects on yeast α-glucosidase and rat intestinal α-glucosidase differed 
according to the chemical structure of flavonoids based on the presence of absence of the  
OH group at the C-3 position of the flavone (quercetin > luteolin; kaempferol > apigenin), 
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hydroxyl substitution on the B ring (flavonol: myricetin = quercetin > kaempferol; 
flavone: luteolin > apigenin), linkage of the B-3 position (isoflavone and flavone groups: 
genistein > apigenin), and 1,2- and 3,4-double bonds and  lack of 4-CO of cyanidin, which 
is responsible for significant inhibition of yeast α-glucosidase. On the other hand, the 
anthocyanidin group and isoflavone group were associated with weak inhibition of rat 
intestinal α-glucosidase activity.  
In the present study, butanol extracts of T. chebula and T. bellirica showed 
stronger inhibitory effects against yeast α-glucosidase activities with IC50 values of 10 
µg/ml and 12 µg/ml, respectively (Table 2.3), than against rat intestinal α-glucosidase 
(Table 2.4). This result was supported by the previous report of Tadera et al. (2006), who 
also found that yeast α-glucosidase was strongly inhibited by flavonoids with IC50 values 
< 15µM, and that rat small intestinal α-glucosidase was weakly inhibited by many 
flavonoids and faintly by the isoflavone and anthocyanidin groups. Sim et al. (2010) 
reported that the substrate specificity is responsible for different reactions because the 
differences of active site of enzyme between N-terminal maltase-glucoamylase and N-
terminal sucrase-isomaltase where maltose could be hydrolyzed efficiently by both N-
terminal sucrase-isomaltase and N-terminal maltase-glucoamylase, because N-terminal 
sucrase-isomaltase has a narrow +1 subsite which accommodates both its α-1,4 (maltose) 
and α-1,6 (isomaltose) substrates, but N-terminal maltase-glucoamylase has a wide +1 
subsite, which is specific for the α-1,4 substrate. The present study results showed 
different reactions against yeast α-glucosidase and rat intestinal α-glucosidase using the 
different extract of three plant leaves, these different reactions might be due to the 
substrate specificity, which was demonstrated by Sim et al. (2010). 
The methanol extracts of T. chebula, T. bellirica, and E. officinalis had IC50 
values for yeast α-glucosidase of 15 µg/ml, 34 µg/ml, and 50 µg/ml, respectively (Table 
2.2). On the other hand, Prihantini et al. (2014) reported that the methanol extract of 
Distylium racemosum showed a strong inhibitory effect on yeast α-glucosidase with an 
IC50 value of 22.6 ± 1.9 µg/ml, followed by Acer mono Maxim and Elaeocarpus sylvestris 
with IC50 values of 56.5 ± 0.9 µg/ml and 74.4 ± 0.9 µg/ml, respectively. These results 
indicated that the α-glucosidase inhibitory activity of methanol extract of T. chebula was 
much stronger than that of D. racemosum, which has been identified as a α-glucosidase 
inhibitor. Nampoothiri et al. (2011) reported that T. bellirica fruit extract showed stronger 
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inhibitory activity against α-glucosidase than E. officinalis fruit extract (IC50 values 0.75 
µg/ml and 1.0 µg/ml, respectively). These results indicated higher inhibitory activities 
than those seen in the present study, which may have been due to the use of different parts 
of the plants (i.e., fruit vs. leaf extracts, respectively).  In addition, Oboh et al. (2014) 
reported that different parts of Persea americana (avocado pear) plants showed different 
α-glucosidase inhibitory activities. 
These results of the present study indicated that the methanol extract of T. 
chebula leaves had the highest inhibitory potency against rat intestinal sucrase inhibitory 
activity (89%), followed by those of E. officinalis (81%) and T. bellirica (70%) (Table 
2.4), while Sabu and Kuttan (2002) reported that the methanol extract of T. bellirica fruits 
showed maximum inhibitory activity (52.74%), followed by those of T. chebula (50.98%) 
and E. officinalis (29.52%). These discrepancies may have been due to differences in the 
experimental approach, because our experiments were performed in vitro, whereas Sabu 
and Kuttan (2002) performed in vivo experiments. In the present study, ethyl acetate 
extract of T. chebula leaves showed 54% inhibition (1 mg/ml) against rat intestinal 
sucrase, while Kim et al. (2011) reported that a high dose of the ethyl acetate portion of 
ethanolic extract of T. chebula fruit (500 mg/kg) reduced the levels of blood glucose. This 
result showed good agreement with those of the present study. 
The results of the present study indicated that the methanol and butanol extracts 
of T. chebula leaves and butanol extracts of T. bellirica leaves showed maximum 
inhibitory effects on yeast α-glucosidase activity. Methanol and butanol extracts of the 
leaves of the three plants, T. chebula, T. bellirica, and E. officinalis, showed the strong 
inhibitory effects on rat intestinal sucrase activity. Thus, the leaves of these three plant 
species may contain antihyperglycemic compounds. Further structural elucidation and 
characterization are required to identify for identifying the biologically active constituents 
of these extracts, and in vivo studies are also necessary to confirm these observations. 
  
 
25 
 
2.5 Conclusions 
The leaf extracts of three Bangladeshi medicinal plants T. chebula, T. bellirica, 
and E. officinalis, showed significant inhibitory effects against α-glucosidase and sucrase 
activities. Butanol and methanol extracts of T. chebula leaves and butanol extract of T. 
bellirica leaves showed significant inhibitory effects on carbohydrate digestive enzymes, 
which may function in controlling postprandial glucose levels. However, further studies 
are needed to determine their potential efficacy in the treatment of diabetes. 
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Chapter 3 
Inhibitory effects of Japanese plant leaf extracts on α-
glucosidase activity 
Abstract 
In this study, methanol extracts of the leaves of nineteen Japanese plant species 
for which there have been no previous reports regarding in vitro α-glucosidase activities, 
were tested for their potential α-glucosidase inhibitory activities. Five plants, Quercus 
phillyraeoides, Mallotus japonicus, Sapium sebiferum, Elaeocarpus sylvestris var. 
ellipticus, and Myrica rubra, showed high inhibitory activity against α-glucosidase with 
IC50 values in the range of 22 – 92 μg/ml. The methanol extracts of these five plants at 1 
mg/ml showed significant inhibitory activity against rat intestinal sucrase. The hexane, 
ethyl acetate, butanol, and water extracts from the five plants were also screened for yeast 
α-glucosidase and rat intestinal sucrase inhibitory activity. The extracts of Q. 
phillyraeoides leaves (ethyl acetate and butanol extracts), M. japonicas leaves (ethyl 
acetate and butanol extracts), and E. sylvestris var. ellipticus leaves (ethyl acetate and 
butanol extracts) showed excellent inhibitory effects against yeast α-glucosidase. 
Methanol, ethyl acetate, and butanol extracts of the five plants also exhibited potent 
inhibitory effects against rat intestinal sucrase. Due to their inhibitory effect, the leaves 
of these five plant species were selected for further investigation to isolate and identify 
the active constituent(s) responsible for the potential antidiabetic activity. 
Keywords: α-glucosidase inhibitor, Diabetes mellitus 
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3.1 Introduction 
Diabetes mellitus is one of the most serious chronic metabolic diseases. The 
number of diabetes patients is increasing in the world not only in developed countries but 
also in developing countries due to changes in lifestyle and food habits. The total diabetic 
population is predicted to increase from 171 million in 2000 to 366 million in 2030 (Wild 
et al., 2004). In Japan, the prevalence of type 2 diabetes is increasing in both adults and 
children; about 13.5% of the Japanese population had type 2 diabetes in 2009 (Neville et 
al., 2009). Therefore, it is clear that diabetes is a very serious concern. 
Blood glucose levels in the human body are increased due to diabetes, often 
leading to various complications, such as cardiovascular disease, eye problems, kidney 
disease, cerebrovascular disease, and limb amputation. Therefore, control of postprandial 
blood glucose levels is important for the treatment of diabetes. Diet and exercise are 
recommended to control blood glucose levels. Although diet and exercise are 
recommended for diabetes management. In most cases, medications are needed for the 
treatment of diabetes. Neville et al. (2009) reported that 51.4% of Japanese people with 
diabetes take oral antidiabetic drugs, while only 25.4% control diabetes by diet. Acarbose 
and voglibose are common α-glucosidase inhibitors used in the treatment of diabetes 
(Playford et al., 2013; Saito et al., 1998). However, they often cause severe 
gastrointestinal side effects. Therefore, an investigation of new α-glucosidase inhibitors 
from natural resources has become an attractive approach for the treatment of diabetes. 
A wide variety of active components of plants have been identified that have 
effects on human health. From ancient times, plants have fulfilled our dietary 
requirements and have also been used for various medical purposes (Kim and Kwon, 
2011). Medicinally active compounds, including carbohydrate digestive enzyme (α-
glucosidase and sucrase) inhibitors, are widely distributed in plants (Mai et al., 2007). 
Some plants have been shown to contain α-glucosidase inhibitors (Wu et al., 2011; 
Alagesan et al., 2012; Chu et al., 2014). 
In this study, the leaves of Japanese plant species were examined for α-
glucosidase inhibitory activity. There have been no previous reports regarding such 
components of these plant species. Chowdhury et al. (2009) reported that among plant 
parts, the leaves are used most commonly against diseases (37%). Chowdhury et al. 
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(2009) also mentioned that most researchers use the leaves of plants as test materials to 
screen for active components. Halim et al. (2007) suggested that the common use of 
leaves was due to the ease of harvesting from plants. The present study was designed to 
investigate the antidiabetic effects of different extracts of the leaves of nineteen Japanese 
woody plant species on yeast α-glucosidase (maltase) and rat intestinal sucrase.  
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3.2 Materials and methods 
3.2.1 Plant collection and extraction 
The leaves of the nineteen plants species (scientific and family names along 
with extract yields are listed in Table 3.1) were collected from Kochi University, Monobe 
campus, Japan. The plant extraction procedure was described in Chapter 2. 
3.2.2 Assay 
The yeast and rat intestinal α-glucosidase inhibitory activity assays were 
performed as described Chapter 2. 
 
  
Table 3.1 Efficiency of methanol extraction from the leaves of nineteen Japanese 
plants 
Scientific Name Family Name Leaf weight (g) 
Quantity of 
methanol 
extract (g) 
Extract yield 
(%, w/w) 
Robinia pseudoacacia Fabaceae 10 2.44 24.4 
Morus bombycis Moraceae 10 1.68 16.8 
Rubus hirsutus Rosaceae 20 4.22 21.1 
Broussonetia kazinoki Moraceae 20 4.76 23.8 
Celtis sinensis var. japonica Cannabaceae 15 2.46 16.4 
Sapium sebiferum Euphorbiaceae 5 1.86 37.2 
Prunus jamasakura  Rosaceae 20 3.39 16.95 
Prunus × yedoensis Rosaceae 10 2.13 21.3 
Cinnamomum camphora Lauraceae 15 2.57 17.1 
Elaeocarpus sylvestris var. 
ellipticus 
Elaeocarpaceae 30 6.72 22.4 
Zelkova serrata  Ulmaceae 10 1.83 18.3 
Melia azedarach var. 
subtripinnata  
Meliaceae 20 4.62 23.1 
Mallotus japonicus  Euphorbiaceae 15 4.84 32.3 
Hedera rhombea  Araliaceae 10 2.37 23.7 
Quercus phillyraeoides  Fagaceae 20 3.60 36 
Lonicera japonica Caprifoliaceae 15 1.92 12.8 
Myrica rubra  Myricaceae 20 2.97 14.9 
Aphananthe aspera  Cannabaceae 10 1.76 17.6 
Hibiscus syriacus  Malvaceae 10 2.20 22 
Percentage extract yield (w/w) was calculated as (dry extract weight/dry starting material weight) × 100 
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3.3 Results 
The methanol extracts of nineteen plants were investigated for their α-
glucosidase activities. Extract concentrations of 200 μg/ml and 50 μg/ml were used for 
preliminary investigations (Table 3.2). Five plants (E. sylvestris var. ellipticus, M. 
japonicus, M. rubra, Q. phillyraeoides, and S. sebiferum) showed high levels of inhibitory 
activity against α-glucosidase (Table 3.2). Therefore, these five plants were analyzed 
comparatively with regard to their α-glucosidase inhibitory activities. The methanol 
extracts of the five plants showed significant in vitro α-glucosidase inhibitory activity 
compared with acarbose (13 mg/ml). Among the five plants, Q. phillyraeoides and E. 
sylvestris var. ellipticus showed the same inhibitory effects (IC50 = 22 μg/ml and 22 μg/ml, 
respectively), followed by S. sebiferum (IC50 = 42 µg/ml), M. japonicus (IC50 = 52 µg/ml), 
and M. rubra (IC50 = 92 µg/ml) (Table 3.3). 
The hexane and water fractions of Q. phillyraeoides leaves had little activity, 
while ethyl acetate and butanol fractions showed stronger α-glucosidase inhibitory 
activities. The Q. phillyraeoides ethyl acetate fraction showed a strong inhibitory effect 
with an IC50 value of 4 µg/ml (Table 3.4). The hexane and water fractions of M. japonicus 
leaves showed no inhibitory activity against α-glucosidase (Table 3.4). The ethyl acetate 
Table 3.2 Effects of methanol extracts of the leaves of nineteen plants against yeast 
α-glucosidase 
Scientific Name Inhibition % 200 µg/ml (%) 50 µg/ml (%) 
Robinia pseudoacacia 93 ± 1 15 ± 3 
Morus bombycis 18 ± 2 1 ± 2 
Rubus hirsutus 85 ± 1 20 ± 3 
Broussonetia kazinoki 5 ± 8 1 ± 8 
Celtis sinensis var. japonica 75 ± 4 4 ± 8 
Sapium sebiferum 62 ± 1 53 ± 3 
Prunus jamasakura  12 ± 2 6 ± 9 
Prunus × yedoensis 17 ± 8 11 ± 2 
Cinnamomum camphora 79 ± 2 6 ± 3 
Elaeocarpus sylvestris var. ellipticus 65 ± 2 60 ± 5 
Zelkova serrata  6 ± 12 7 ± 1 
Melia azedarach var. subtripinnata  99 ± 1 91 ± 2 
Mallotus japonicus  7 ± 9 3 ± 9 
Hedera rhombea  82 ± 0 27 ± 0 
Quercus phillyraeoides  30 ± 7 0 ± 1 
Lonicera japonica 21 ± 2 0 ± 1 
Myrica rubra  95 ± 6 11 ± 2 
Aphananthe aspera  18 ± 2 1 ± 9 
Hibiscus syriacus  86 ± 1 48 ± 2 
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and butanol fractions of M. japonicus leaves showed significant inhibitory activities, with 
IC50 values of 10 µg/ml and 25 µg/ml, respectively (Table 3.4). The hexane and water 
fractions of S. sebiferum leaves were also less active than the ethyl acetate and butanol 
fractions, the latter of which had IC50 values of 14 µg/ml and 16 µg/ml, respectively 
(Table 3.4). The hexane fraction of E. sylvestris var. ellipticus leaves was inactive, while 
the ethyl acetate, butanol, and water fractions showed α-glucosidase inhibitory activities, 
with IC50 values of 6 µg/ml, 7 µg/ml, and 9 µg/ml, respectively (Table 3.4). The hexane 
fraction of M. rubra leaves was inactive. The ethyl acetate fraction of M. rubra was less 
active than the butanol and water fractions, the latter of which had IC50 values of 15 µg/ml 
and 8 µg/ml, respectively (Table 3.4). 
In this study, the inhibitory effects of leaf extracts from the five plant species 
against sucrase activity were determined and compared with that of acarbose (91%, Table 
3.5). Methanol extracts of E. sylvestris var. ellipticus, M. japonicus, M. rubra, Q. 
phillyraeoides, and S. sebiferum leaves at 1 mg/ml in the reaction mixtures showed strong 
 Table 3.3 Inhibitory effects of fractionated extracts of five 
medicinal plants on α-glucosidase activity. 
 
 Plant Name IC50  µg/ml  
 Quercus phillyraeoides  22   
 Mallotus japonicus  52   
 Sapium sebiferum  42   
 Elaeocarpus sylvestris var. ellipticus  22   
 Myrica rubra  92   
 Acarbose (positive control: ) 13,000  
 Acarbose was used as a positive control. 
IC50: Concentration of the antagonist that inhibited the enzyme reaction by 50%. 
 
Table 3.4 Inhibitory effects of fractionated extracts of five medicinal plants on yeast 
α-glucosidase activity 
Plant Name 
IC50 µg/ml 
Hexane 
extract 
Ethyl acetate 
extract 
Butanol 
extract 
Water 
extract 
Quercus phillyraeoides  86  4  6  83  
Mallotus japonicus  NA 10  25  NA 
Sapium sebiferum  65  14  16  135  
Elaeocarpus sylvestris var. ellipticus  NA 6  7  9  
Myrica rubra  NA 84  15  8  
Acarbose (positive control) 13,000 
Acarbose was used as a positive inhibitory molecule. 
IC50: Concentration of the antagonist that inhibited the enzyme reaction by 50%. 
NA: No activity 
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inhibitory effects against sucrase activity (Table 3.5), with that of Q. phillyraeoides 
showing the greatest effect (90%). 
The hexane and water extracts of five plant species showed weak inhibitory 
effects on rat intestinal sucrase activity (Table 3.5). The ethyl acetate and butanol extracts 
of Q. phillyraeoides were shown to inhibit the enzyme activity by 63% and 57%, 
respectively (Table 3.5). However, the hexane and water extracts of Q. phillyraeoides 
leaves showed low levels of inhibition on sucrase activity, while acarbose (positive 
control) showed 91% inhibition of the enzyme activity at a concentration of 1 mg/ml 
(Table 3.5). 
The ethyl acetate and butanol extracts of M. japonicus leaves showed the 
greatest inhibitory effects (57% and 67%, respectively), and the weakest effects were 
observed for hexane and water extracts of M. japonicus (35% and 50%, respectively). 
Table 3.5 Inhibitory effects of extracts of the leaves of five plants on rat intestinal 
sucrase and yeast α-glucosidase. 
Plant Name Extract Type 
% of rat intestinal sucrase 
inhibitory effect 
% of yeast α-glucosidase 
inhibitory effect 
1mg/ml 200 µg/ml 
Quercus phillyraeoides  Methanol 90 ± 4 99 ± 0.6 
Hexane 43 ± 21 69 ± 6 
Ethyl acetate 63 ± 6 100 ± 0 
Butanol 57 ± 18 99 ± 0 
Water 41 ± 7 81 ± 8 
Mallotus japonicus  Methanol 73 ± 9 86 ± 2 
Hexane 35 ± 2 20 ± 3 
Ethyl acetate 57 ± 15 99 ± 0 
Butanol 67 ± 11 86 ± 1 
Water 50 ± 5 40 ± 1 
Elaeocarpus sylvestris var. 
ellipticus  
Methanol 77 ± 1 65 ± 3 
Hexane 13 ± 5 12 ± 3 
Ethyl acetate 70 ± 5 91 ± 2 
Butanol 62 ± 2 83 ± 6 
Water 27 ± 10 94 ± 2 
Myrica rubra  Methanol 76 ± 0 82 ± 0 
Hexane 30 ± 6 28 ± 6 
Ethyl acetate 41 ± 8 73 ± 2 
Butanol 48 ± 4 94 ± 1 
Water 28 ± 9 99 ± 0 
Sapium sebiferum  
 
Methanol 69 ± 8 62 ± 4 
Hexane 51 ± 18 81 ± 0.4 
Ethyl acetate 63 ± 17 92 ± 1 
Butanol 76 ± 6 99 ± 2 
Water 56 ± 17 58 ± 1 
Acarbose (positive control)  91 ± 3 5  ± 4 
The values are expressed as means ± standard deviation, n =3. 
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The ethyl acetate and butanol extracts of E. sylvestris var. ellipticus leaves showed the 
greatest inhibitory effects (70% and 62%, respectively) against sucrase activity (Table 
3.5). The butanol extract of M. rubra leaves showed an inhibitory effect of 48%, while 
the hexane, ethyl acetate, and water extracts showed lower inhibitory activities of 30%, 
41%, and 28%, respectively (Table 3.5). The hexane, ethyl acetate, butanol, and water 
extracts of S. sebiferum showed high inhibitory activities of 51%, 63%, 76%, and 56%, 
respectively (Table 3.5).  
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3.4 Discussion 
In this study, we used acarbose as a positive control for both yeast α-glucosidase 
and rat intestinal α-glucosidase. Acarbose did not show a stronger inhibitory effect against 
yeast α-glucosidase, whereas it showed the greatest inhibitory effect against rat intestinal 
α-glucosidase. The differences in the inhibitory activities against these two enzymes may 
have been due to their structural differences (Chiba, 1997). It was confirmed that the 
experimental protocols were identical because acarbose was used as a positive control for 
both enzymes. It is important to note that acarbose has been used clinically to treat 
diabetes mellitus. Therefore, several groups have used acarbose as a positive control to 
identify or screen for suitable natural antidiabetic compounds (Zhang et al., 2014; 
Ghadyale et al., 2011; Wu et al., 2011).  
Although acarbose has been clinically approved for use as an antidiabetic 
medication, Shai et al. (2010) reported that acarbose showed a weak inhibitory effect 
against yeast α-glucosidase. This result was compatible with the present study, in which 
acarbose showed only a weak inhibitory effect against yeast α-glucosidase with an IC50 
value of 13 mg/ml, while the five plant extracts showed strong inhibitory effects against 
the activity of this enzyme (Table 3.4). 
The methanol, ethyl acetate, and butanol extracts of the leaves from the five 
plant species, Q. phillyraeoides, M. japonicus, S. sebiferum, E. sylvestris var. ellipticus, 
and M. rubra, showed stronger inhibitory effects against yeast α-glucosidase than rat 
intestinal sucrase (Supplemental Data, Table 3.5). At 200 μg/ml, methanol, ethyl acetate, 
and butanol extracts of Q. phillyraeoides inhibited yeast α-glucosidase activity by 99%, 
100%, and 99%, respectively, while at 1 mg/ml, the inhibitory effects of these extracts on 
rat intestinal sucrase were lower at 90%, 63%, and 57%, respectively. This result was 
similar by those of Babu et al. (2004), who reported that methanol extracts of various 
plants had greater inhibitory effects against yeast α-glucosidase than mammalian α-
glucosidase. 
The ethyl acetate and butanol fractions of Q. phillyraeoides had IC50 values for 
yeast α-glucosidase of 4 μg/ml and 6 μg/ml, respectively (Table 3.4). Dewi et al. (2007) 
reported that the ethyl acetate extract of koji Aspergillus terreus exhibited a strong 
inhibitory effect against α-glucosidase with an IC50 value of 8.6 µg/ml. These findings 
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indicated that α-glucosidase inhibitory activity of Q. phillyraeoides was stronger than that 
of koji Aspergillus terreus, which is known as a potent α-glucosidase inhibitor. 
These results of the present study indicated that the methanol extract of Q. 
phillyraeoides leaves showed the strongest inhibitory effect against rat intestinal sucrase 
activity (90%), followed by those of E. sylvestris var. ellipticus (77%), M. rubra (76%), 
M. japonicus (73%), and S. sebiferum (69%) (Supplemental Data, Table 3.5). On the other 
hand, Kajaria et al. (2013) reported that ethanolic extract of Shirishadi showed a strong 
inhibitory effect of 45% (1 mg/ml) against α-glucosidase. The results suggested that α-
glucosidase inhibitory activity of Q. phillyraeoides was higher than that of ethanolic 
extract of Shirishadi, which has been identified as a potent α-glucosidase inhibitor. 
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3.5 Conclusions 
The results of the present study indicated that different extracts of five plants 
(E. sylvestris var. ellipticus, M. japonicus, M. rubra, Q. phillyraeoides, and S. sebiferum) 
showed strong inhibitory effects against yeast α-glucosidase activities. Q. phillyraeoides 
(ethyl acetate) leaf extract showed the greatest inhibitory effect against yeast α-
glucosidase. Methanol, ethyl acetate, and butanol extracts of E. sylvestris var. ellipticus, 
M. japonicus, M. rubra, Q. phillyraeoides, and S. sebiferum showed strong inhibitory 
effects against sucrase activity. The leaves of these five plant species should be 
investigated further to purify and identify the specific compound(s) responsible for the 
observed potential antidiabetic activities. 
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Chapter 4 
Isolation and purification of α-glucosidase inhibitory 
constituents from Terminalia chebula, Mallotus japonicus, 
and Quercus phillyraeoides 
Abstract 
α-Glucosidase inhibitors can delay the carbohydrate digestion process in the 
small intestine and control postprandial blood glucose level. In this study, butanol extract 
of Terminalia chebula, butanol extract of Mallotus japonicus, and ethyl acetate extract of 
Quercus phillyraeoides were screened for biologically active compounds using a 
fractionation technique and yeast α-glucosidase inhibitory activity assay. Two fractions 
(TCB-1 and TCB-2) were isolated from the leaves of T. chebula, one fraction (MJB-1) 
was isolated from the leaves of M. japonicus, and three fractions (QPE 1, QPE-2, and 
QPE-3) were isolated from the leaves of Q. phillyraeoides. The half maximal 
concentrations (IC50) of TCB-1, TCB-2, and MJB-1 fractions were 2 µg/ml, 3 µg/ml, and 
10 µg/ml, respectively, and those of QPE 1, QPE-2, and QPE-3 fractions were 1.6 µg/ml, 
26 µg/ml, and 27 µg/ml, respectively. All six fractions showed significant in vitro α-
glucosidase inhibitory activity compared with acarbose (IC50 value: 13 mg/ml). These 
results suggest that the three plants may be useful as sources of natural α-glucosidase 
inhibitors for use in the treatment of diabetes. 
Keywords: α-glucosidase inhibitor, diabetes, Terminalia chebula, Mallotus japonicus, 
Quercus phillyraeoides 
  
 
38 
 
4.1 Introduction 
We screened for α-glucosidase inhibitors from the leaf extracts of 22 plant 
species from Bangladesh and Japan to use in the treatment of diabetes (Chapters 2 and 3). 
The dry leaves were extracted with methanol and then dried using a rotary evaporator. 
The dry extract was partitioned in 30% hexane/70% methanol solution, followed by 
fractionation with ethyl acetate, butanol, and water. Each fraction was evaporated under 
reduced pressure to provide hexane, ethyl acetate, butanol, and water fractions. Different 
extracts of eight plant species showed significant inhibitory effects against yeast α-
glucosidase.  
As discussed in Chapter 2, the leaf extracts of three Bangladeshi medicinal 
plants T. chebula, T. bellirica, and E. officinalis showed significant inhibitory effects 
against yeast α-glucosidase. The main purpose of this study was to find new traditional 
medicinal plants for diabetes among Bangladeshi plants, but the butanol extract of T. 
chebula was selected for fractionation because it showed high inhibitory effect against 
yeast α-glucosidase.  
Chapter 3 discussed the screening of leaf extracts from 19 plant species for 
yeast α-glucosidase inhibitory activities. Among them, different extracts of five plants 
(Elaeocarpus sylvestris var. ellipticus, Mallotus japonicus, Myrica rubra, Quercus 
phillyraeoides, and Sapium sebiferum) showed strong inhibitory effects against yeast α-
glucosidase. Among these plants, ethyl acetate extract of Q. phillyraeoides and butanol 
extract of M. japonicus showed the strongest inhibitory effects against yeast α-
glycosidase. The main purpose of this study was to find new compounds for treatment of 
diabetes from plant leaves collected in Japan. 
Further chemical investigation of the butanol extract of T. chebula, butanol 
extract of M. japonicus, and ethyl acetate extract of Q. phillyraeoides are necessary to 
develop new pharmaceutical preparations. Therefore, these three plants were screened for 
biologically active compounds using a fractionation technique and yeast α-glucosidase 
inhibitory activity assay.  
Many biologically active compounds have been discovered from plants and 
reported to show antidiabetic effects. Alkaloids, terpenoids, and their derivates have been 
used for their anti-hyperglycemic activity from ancient times (Erememisoglu et al., 1995). 
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Flavonoids are polyphenolic compounds that play important roles in reducing blood 
glucose level (Babu et al., 2013). 
In the present study, a fractionation technique was used for isolation and 
purification of yeast α-glucosidase inhibitors from plant extracts. Silica gel column 
chromatography (Si-gel CC), medium-pressure liquid chromatography (MPLC), and 
high-performance liquid chromatography (HPLC) were used to separate and purify 
different components from mixtures of plant extracts. The collected fractions were 
examined by thin layer chromatography (TLC) for desired components. 
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4.2 Materials and methods 
4.2.1 Plant materials 
The butanol extract of T. chebula (Chapter 2), butanol extract of M. japonicas 
(Chapter 3), and ethyl acetate extract of Q. phillyraeoides (Chapter 3) fractions were used 
for isolation and purification. 
4.2.2 Isolation and purification of α-glucosidase inhibitors from T. chebula  
4.2.2.1 Silica gel column chromatography (Si-gel CC) 
Silica gel column chromatography was used to separate components from the 
active fraction. An open glass column (54cm × 4cm id.; Vidrex, Fukuoka, Japan) and 
silica gel (FL100D; Fuji Silysia, Kasugai, Japan) were used for column chromatography. 
Cotton was added to the bottom of the column to prevent the silica from being washed 
out. For column preparation, dry silica gel was suspended in 100% ethyl acetate and 
poured into the column. The stopcock was opened for flowing out ethyl acetate up to an 
equal level with silica gel. After 5 minutes, the sample was poured into the silica gel 
column. For sample preparation, a small amount of 50% methanol was mixed with the 
sample. Completely soluble samples were loaded directly onto the silica gel column. The 
sample was eluted with solvent mixtures and fractions of 50 ml were collected. If the 
sample was not soluble in methanol, about 1 ml of insoluble sample was poured into the 
silica gel-containing flask and evaporated until the entire sample had been used. The 
completely evaporated sample was dried by lyophilization.  
The butanol extract of T. chebula (394 mg) was mixed with 50% methanol and 
loaded onto the column followed by elution with a step gradient procedure, which 
gradually increases in polarity. In the first step, the sample was eluted with ethyl 
acetate:methanol:water (16:2:1, 950 ml v/v/v) to yield fractions 1 – 19. In the second step, 
the sample was eluted with ethyl acetate:methanol:water (8:2:1, 1050 ml v/v/v) to yield 
fractions 20 – 40. In the third step, the sample was eluted with ethyl 
acetate:methanol:water (4:2:1, 500 ml v/v/v) to yield fractions 41 – 53 and finally washed 
with methanol (500 ml).  
4.2.2.2 High-performance liquid chromatography (HPLC) 
HPLC was used for separation of different compounds from the active fractions 
based on their polarity and hydrophobic interactions. The HPLC system consisted of a 
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pump (PU-2089 plus; Jasco, Tokyo, Japan), column oven (CO-2065 plus; Jasco), and 
detector (UV-2077; Jasco). A stainless steel column was used in this experiment, and the 
column oven was set at 40°C. An octadecyl silyl (ODS) column was used for separation 
of active fractions. The UV detector was used to monitor fractions and compounds eluted 
from the column. The ODS column is recommended for reverse-phase chromatography 
in which a polar mobile phase and a non-polar stationary phase are used. This allows non-
polar molecules (hydrophobic) coupled to carrier beads (silica C18) and polar molecules 
(hydrophilic) to pass swiftly through the stationary phase. Polar solvents (methanol and 
water) were used to elute the binding molecules in this study. The sample was dissolved 
in a small amount of methanol and fractions were collected by peak assignment.  
For final purification, T. chebula extract (131 mg, B1 fraction) was subjected 
to HPLC under the following conditions: column, YMC pack ODS-A A-301 100 × 4.6 
mm I. D. with a particle size of 5 µm and pore size of 120 Å; isocratic elution, 25% 
methanol; flow rate, 1.5 ml/min; detection, UV 210 nm; and chart speed, 15 cm/h. The 
injection volume was 20 µl. 
4.2.2.3 Thin layer chromatography (TLC) 
All chromatographic fractions were checked by thin layer chromatography 
(TLC) and the fractions that showed similar spots were combined for yeast α-glucosidase 
assay. TLC was performed on precoated plates (Silica gel 60 F254; Merck, Tokyo, Japan; 
RP-18 WF254s; Merck, Darmstadt, Germany). The chromatographic fractions were 
spotted onto the TLC plate. The developing tank was prepared with a suitable solvent. 
The TLC plate was then dipped into the developing tank for a few minutes until the 
solvent ascended to the top of the plate. The TLC plate was visualized under UV light 
and developed by spraying with ethanol: 20% H2SO4 (1:1) and heating at 110°C to 
identify the presence of antidiabetic compounds.  
4.2.3 Isolation and purification of α-glucosidase inhibitors from M. japonicus  
4.2.3.1 Silica gel column chromatography (Si-gel CC) 
The column and sample preparation process were as described above for Si-gel 
CC of T. chebula (Subsection 4.2.2.1) but the sample volume, number of fractions, and 
proportions of solvents were different, as outlined below. 
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The butanol extract of M. japonicus (2.5 g) was mixed with 50% methanol and 
loaded onto the column. In the first step, the sample was eluted with ethyl 
acetate:methanol (4:1, 650 ml v/v) to yield fractions 1 – 13. In the second step, the sample 
was eluted with ethyl acetate:methanol:water (16:2:1, 650 ml v/v/v) to yield fractions 14 
– 26. In the third step, the sample was eluted with ethyl acetate:methanol:water (6:2:1, 
450 ml v/v/v) to yield fractions 27 – 36 and finally washed with methanol (500 ml).  
4.2.3.2 Medium-pressure liquid chromatography (MPLC) 
Medium-pressure liquid chromatography (MPLC) was used to separate 
components from the active fraction. The active fraction was subjected to MPLC using a 
glass column (YMC-GEL ODS-A, 15 cm × 16 mm I.D.) with a particle size of 150 μm 
and pore size of 120 Å. The sample dissolved in a small amount of methanol, and the 
dissolved sample was loaded onto the column. The fractions were collected using a 
fraction collector (SF-3120; Advantec, Ehime, Japan). 
The butanol fraction of M. japonicus extract (2015 mg, B2 fraction) was 
separated by MPLC with the following elution conditions: elution gradient, 0% – 100% 
methanol; and flow rate, 1.5 ml/min. The samples were run for 15 hours, and the volume 
of each fraction was 15 ml. 
4.2.3.3 High-performance liquid chromatography (HPLC) 
The high-performance column chromatography (HPLC) system (pump, oven, 
and detector), ODS column, and sample preparation were as described for T. chebula 
(Subsection 4.2.2.2), but with the sample volume, column conditions, and injection 
volume outlined below. 
For final purification, M. japonicus extract (247 mg, B2-4 fraction) was 
subjected to HPLC with the following conditions: column, YMC pack ODS-5-ST 150 × 
20 mm I. D. with a particle size of 5 µm and pore size of 120 Å; isocratic elution, solvent 
50% methanol; flow rate, 5 ml/min; detection, UV 210 nm; and chart speed, 15 cm/h. The 
injection volume was 50 µl. 
4.2.3.4 Thin layer chromatography (TLC) 
All chromatographic fractions were checked by thin layer chromatography 
(TLC) according to the procedure described for T. chebula (Subsection 4.2.2.3). 
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4.2.4 Isolation and purification of α-glucosidase inhibitors from Q. phillyraeoides 
4.2.4.1 Silica gel column chromatography (Si-gel CC) 
The column and sample preparation process were as described for Si-gel CC of 
T. chebula (Subsection 4.2.2.1) but with the sample volume, number of fractions, and 
proportion of solvents outlined below. 
The ethyl acetate extract of Q. phillyraeoides (368 mg, E1-1 fraction) was 
mixed with 50% methanol and loaded onto the column. The column was eluted with an 
isocratic system. A range of ratios was used for the column: ethyl acetate:methanol:water, 
8:2:1, 950 ml v/v/v to yield 19 fractions.  
4.2.4.2 Medium-pressure liquid chromatography (MPLC) 
The column, fraction collector, and sample preparation process were as 
described for MPLC of M. japonicus (Subsection 4.2.3.2), but with the sample volume, 
elution conditions, sample run time, and fraction volumes outlined below. 
The ethyl acetate extract of Q. phillyraeoides (2 g) was separated by MPLC 
with the following elution conditions: gradient elution, 50% – 100% methanol; and flow 
rate, 2.5 ml/min. The samples were run for 9 hours, and the volume of each fraction was 
11.25 ml. 
The ethyl acetate extract of Q. phillyraeoides (910 mg, E1 fraction) was 
separated by MPLC with the following elution conditions: gradient elution, 80% – 100% 
methanol; and flow rate, 2.0 ml/min. The samples were run for 10 hours, and the volume 
of each fraction was 9.8 ml. 
4.2.4.3 High-performance liquid chromatography (HPLC) 
The HPLC system (pump, oven, and detector), ODS column, and sample 
preparation process were as described for HPLC of T. chebula (Subsection 4.2.2.2), but 
with the sample volume, column conditions, and injection volume outlined below. 
For final purification, Q. phillyraeoides extract (197 mg, E1-1-1 fraction) was 
subjected to HPLC under the following conditions: column, YMC pack ODS-A A-301 
100 × 4.6 mm I. D. with a particle size of 5 µm and pore size of 120 Å; isocratic elution, 
35% methanol; flow rate, 1.0 ml/min; detection, UV 210 nm; and chart speed, 15 cm/h. 
The injection volume was 20 µl. 
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For final purification, Q. phillyraeoides extract (30 mg, E2 fraction) was 
subjected to HPLC under the following conditions: column, YMC pack ODS-5-ST 150 
× 20 mm I. D. with a particle size of 5 µm and pore size of 120 Å; isocratic elution, 60% 
methanol (0.05% trifluoroacetic acid); flow rate, 5.0 ml/min; detection, UV 210 nm; and 
chart speed, 15 cm/h. The injection volume was 50 µl. 
Q. phillyraeoides extract (130 mg, E4 fraction) was subjected to HPLC with 
the following conditions: column, YMC pack ODS-5-ST 150 × 20 mm I. D. with a 
particle size of 5 µm and pore size of 120 Å; isocratic elution, 60% methanol (0.05% 
trifluoroacetic acid); flow rate, 5.0 ml/min; detection, UV 210 nm; and chart speed, 15 
cm/h. The injection volume was 50 µl. 
For final purification, Q. phillyraeoides extract (10 mg, E4-2 fraction) was 
subjected to HPLC with the following conditions: column, YMC pack ODS-5-ST 100 × 
4 mm I. D. with a particle size of 5 µm and pore size of 120 Å; isocratic elution, 50% 
methanol; flow rate, 1.0 ml/min; detection, UV 210 nm; and chart speed, 15 cm/h. The 
injection volume was 20 µl.  
4.2.4.4 Thin layer chromatography (TLC) 
All chromatographic fractions were checked by thin layer chromatography 
(TLC) according to the procedure described for T. chebula (Subsection 4.2.2.3). 
4.2.5 Yeast α-glucosidase inhibitory assay 
The yeast α-glucosidase inhibitory activity assay was performed as described 
in Chapter 2. 
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4.3 Results 
 4.3.1 T. chebula 
The butanol extract was used as the starting material for separation of 
compounds with inhibitory activities of α-glucosidase in T. chebula (Fig. 4.1). The 
butanol extract of T. chebula was separated by silica gel column chromatography (step 
gradient) with varying concentrations of the solvent, ethyl acetate:methanol:water (16:2:1, 
8:2:1, 4:2:1), yielding 53 fractions and finally the sample was washed with methanol, 
yielding 54 number of fraction. Each fraction was checked by TLC and according to the 
spot pattern, seven combined fractions were obtained as follows: B1 (Fr.1 – Fr.4), B2 
(Fr.5 – Fr.9), B3 (Fr.10 – Fr.21), B4 (54, methanol fraction), B5 (Fr.22 – Fr.34), B6 
(Fr.35 – Fr.40), and B7 (Fr.41 – Fr.53) (data not shown). Four fractions were checked by 
 Table 4.1 Inhibitory effects of B1 – B7 fractions from 
Terminalia chebula butanol extract against yeast α-
glucosidase. 
 
 Fraction IC50  µg/ml  
 B1 6   
 B2 14   
 B3 6   
 B4 7   
 B5 7   
 B6 9   
 B7 34   
 
Fig. 4.1 Scheme of the separation of fractions from Terminalia chebula butanol extract. 
 
 Butanol layer (394 mg) 
Si-gel CC (step gradient) 
B2 (21 mg) 
 
B3 (25 mg) B4 (18 mg) B5 (5 mg) B6 (10 mg) B7 (5 mg) B1 (131 mg) 
 
HPLC 
B1-3 (11 mg) B1-2 (5 mg)  TCB-1 (B1-1) 39 mg 
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TLC (Fig. 4.2). Among them, spots appeared in the B1 fraction. These fractions showed 
α-glucosidase inhibitory activities with IC50 values of 6 μg/ml (B1), 14 μg/ml (B2), 6 
μg/ml (B3), 7 μg/ml (B4), 7 μg/ml (B5), 9 μg/ml (B6), and 34 μg/ml (B7) (Table 4.1). 
Among those fractions, the B1 fraction showed the greatest inhibitory effect with an IC50 
value of 6 µg/ml. Thereafter, the B1 fraction was purified by HPLC to yield B1-1 (I), B1-
2 (II), and B1-3 (remaining part, III) fractions. As shown in Fig. 4.3, fractions were 
 
 
1   2     3 
Fig. 4.2 Thin layer chromatography of B1 – B4 fractions of T. chebula butanol 
extract. Chromatographic fractions were checked by normal-phase thin layer 
chromatography (silica gel 60 F254) using a mixture of ethyl acetate : methanol : 
water (8:2:1). Spots appeared in fraction B1. 
 
 
 
Fig. 4.3 High-performance liquid chromatography (HPLC) of B1 fraction of T. 
chebula butanol extract. The peaks were found at retention times of 6 (I, B1-1) and 
10 (II, B2-4-2) minutes by UV monitoring at 210 nm. 
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collected at retention times of 6 (I) and 10 (II) minutes by UV monitoring at 210 nm. The 
collected fractions showed α-glucosidase inhibitory activities with IC50 values of 2 μg/ml 
(B1-1), 3 μg/ml (B1-2), and 20 μg/ml (B1-3) (Table 4.2). Among these fractions, B1-1 
(TCB-1) and B1-2 (TCB-2) fractions showed strong inhibitory effects against yeast α-
glucosidase (Table 4.2). 
4.3.2 M. japonicus 
The butanol extract was used as the starting material for separation of 
compounds with inhibitory activities against α-glucosidase in M. japonicus (Fig. 4.4). 
The butanol extract of M. japonicus was fractionated by silica gel column 
chromatography (step gradient) and eluted with varying concentrations of solvent ethyl 
acetate:methanol (4:1), ethyl acetate:methanol:water (16:2:1), ethyl 
acetate:methanol:water (6:2:1). Finally, 37 fractions were collected by silica gel column 
chromatography. Each fraction was checked by TLC and according to spot pattern, seven 
 Table 4.2 Inhibitory effects of B1-1, B1-2, and B1-3 fractions 
from B1 fraction of Terminalia chebula butanol 
extract against yeast α-glucosidase. 
 
 Fraction IC50  µg/ml  
 B1-1 (TCB-1) 2   
 B1-2 (TCB-2) 3   
 B1-3 20  
 
Fig. 4.4 Scheme of the separation of fractions from Mallotus japonicus butanol extracts. 
 Butanol layer (2.5 g) 
B1 (165 mg) 
 
B2 (2015 mg) B3 (137 mg) B4 (22 mg) B5 (17 mg) B6 (33.9 mg) B7 (30 mg) 
B2-1 (1069 mg) B2-2 (155 mg)  B2-3 (472 mg) 
MPLC  
B2-4 (247 mg) B2-5 (47 mg) 
MPB 1 (B2-4-2) (76 mg) 
HPLC 
Si-gel CC (step gradient  
 B2-4-1 (8 mg) 
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combined fractions were obtained as follows: B1 (Fr.1 – Fr.2), B2 (Fr.3 – Fr.5), B3 (Fr.6 
– Fr.13), B4 (Fr.14 – Fr.18), B5 (Fr.19 – Fr.30), B6 (Fr.31 – Fr.36), and B7 (37) (data not 
shown). Six fractions were then checked by TLC using the solvent, ethyl 
acetate:methanol:water (6:2:1, 9 ml v/v/v) (Fig. 4.5A) and 50% methanol (Fig. 4.5B). The 
spots appeared in the B2 fraction on both TLC plates. These fractions showed α-
glucosidase inhibitory effects, with IC50 values of 28 μg/ml (B1), 11 μg/ml (B2), 40 μg/ml 
(B3), 33 μg/ml (B4), 33 μg/ml (B5), and 38 μg/ml (B6); the B7 fraction showed no 
inhibitory activity (Table 4.3). Among these fractions, B2 fraction showed the highest 
 
 
Fig. 4.5 Thin layer chromatography (TLC) of B1 – B6 fractions of M. japonicus 
butanol extract. 
A: Chromatographic fractions were checked by normal-phase thin layer 
chromatography (silica gel 60 F254) using a mixture of ethyl acetate:methanol:water 
(6:2:1). The spots appeared in fraction B2.  
B: Chromatographic fractions were checked by reverse-phase thin layer 
chromatography (RP-18 F254s) using 50% methanol. The spots also appeared in 
fraction B2. 
 
 Table 4.3 Inhibitory effects of B1 – B7 fractions from Mallotus 
japonicus butanol extract against yeast α-glucosidase. 
 
 Fraction IC50  µg/ml  
 B1 28   
 B2 11   
 B3 40   
 B4 33   
 B5 33   
 B6 38   
 B7 NA   
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inhibitory effect with an IC50 value of 11 µg/ml (Table 4.3). The B2 fraction was then 
fragmented by MPLC and yielded 120 fractions. Chromatographic fractions were 
examined by TLC (data not shown). According to the spot pattern, five combined 
fractions were obtained as follows: B2-1 (1 – 29), B2-2 (30 – 44), B2-3 (45 – 65), B2-4 
(66 – 105), and B2-5 (106 – 120) (data not shown). The B2-1 – B2-5 fractions were then 
checked by TLC (Fig. 4.6). Among these fractions, spots appeared in the B2-4 fraction. 
The B2-1 – B2-5 fractions were checked for α-glucosidase inhibitory activities, and 
showed IC50 values of 16 µg/ml (B2-1), 17 µg/ml (B2-2), 16 µg/ml (B2-3), 10 µg/ml (B2-
 
 
Fig. 4.6 Thin layer chromatography of B2-1 – B2-5 fractions of M. japonicus 
butanol extract. 
A: Chromatographic fractions were checked by normal-phase thin layer 
chromatography (silica gel 60 F254) using a mixture of ethyl acetate:methanol:water 
(6:2:1). Spots were not clear in B2-1 – B2-5 fractions.  
B: Chromatographic fractions were checked by reverse-phase thin layer 
chromatography (RP-18 F254s) using 50% methanol. B2-1 – B2-3 fractions showed 
smeared spot, B2-4 fraction showed a clear spot. B2-5 fraction did not show any 
spots 
 
 Table 4.4 Inhibitory effects of B1 – B7 fractions from Mallotus 
japonicus butanol extract against yeast α-glucosidase. 
 
 Fraction IC50  µg/ml  
 B2-1 16   
 B2-2 17   
 B2-3 16   
 B2-4 10   
 B2-5 48   
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4), and 48 µg/ml (B2-5) (Table 4.4). Among these fractions, the B2-4 fraction showed 
maximum inhibitory activity. According to the spot and inhibitory activity, the B2-4 
fraction was selected for further fractionation, and HPLC yielded B2-4-1 (I), B2-4-2 (II), 
and B2-4-3 (remaining part, III) fractions (Fig. 4.7). The fractions were collected at 
retention times of 8 (I) and 15 (II) minutes by UV monitoring at 210 nm. The B2-4-2 (II) 
fraction showed an individual peak (Fig. 4.7). The fractions were then checked by TLC; 
 
 
Fig. 4.7 High-performance liquid chromatography (HPLC) of B2-4 fraction of M. 
japonicus butanol extract. The peaks were found at retention times of 8 (I, B2-4-1) 
and 15 (II, B2-4-2) minutes by UV monitoring at 210 nm. 
 
 
 
Fig. 4.8 Thin layer chromatography (TLC) of B2-4-1 and B2-4-2 fraction of M. japonicus 
butanol extract. Chromatographic fractions were checked by reverse-phase thin layer 
chromatography (RP-18 F254s) using 50% methanol. Lane 1 (B2-4 main) showed a clear spot and 
lane 2 (B2-4-3) showed a smeared spot, lane 3 (B2-4-1) showed no spot, and lane 4 (B2-4-2) 
showed a clear spot. 
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lane 1 (B2-4) showed a clear spot, lane 2 (B2-4-3) showed a smeared spot, B2-4-1 showed 
no spot, and B2-4-2 fraction showed a clear spot (Fig. 4.8). These fractions were 
examined for α-glucosidase inhibitory activities, and showed IC50 values of 17 µg/ml 
(B2-4-1) and 10 µg/ml (B2-4-2) (Table 4.5). The B2-4-2 fraction showed the highest 
inhibitory effect against yeast α-glucosidase.  
4.3.3 Q. phillyraeoides 
The ethyl acetate extract was used as the starting material for separation of 
compounds with inhibitory activities against α-glucosidase in Q. phillyraeoides (Fig. 4.9). 
 Table 4.5 Inhibitory effects of B2-4-1 and B2-4-2 fractions from 
B2-4 fraction of Mallotus japonicus butanol extract 
against yeast α-glucosidase. 
 
 Fraction IC50  µg/ml  
 B2-4-1 17   
 B2-4-2 (BJB-1) 10   
 
Fig. 4.9 Scheme of the separation of fractions from Quercus phillyraeoides ethyl acetate 
extract. 
 
E6 (174 mg) E5 (148 mg) E3 (9 mg) E2 (30 mg) E1 (910 mg) 
Si-gel CC  
E1-1-3 (12 mg) 
E1-1-2 (26 mg) 
E1-1-3 (30 mg) 
E4 (130 mg) 
QPE2 (E2-1) 11 mg 
MPLC HPLC (ODS) 
E1-1 (368 mg)        E1-2 (134 mg)   E1-3 (62 mg)   E1-4 (15 mg)            
E1-1-1 (197 mg) 
HPLC (ODS) 
QPE-1(E-1-1-1-1) 82 mg 
MPLC 
HPLC (ODS) 
 
HPLC  
HPLC 
QPE-4 (E-4-2-1) 2 mg  
Ethyl acetate extracts (2 g) 
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The ethyl acetate extract of Q. phillyraeoides was separated by MPLC (120 tubes) and 
collected fractions were checked by TLC (Fig. 4.10A). Lanes 40 – 60 showed clear spots 
with different mobilities, so it was difficult to distinguish between these lanes. According 
to spot appearing condition, it was checked more details by TLC (Fig. 4.10B). Based on 
 
Fig. 4.10 Thin layer chromatography (TLC) of Q. phillyraeoides ethyl acetate 
extract. 
A: Chromatographic fractions were checked by normal-phase thin layer 
chromatography (silica gel 60 F254) using a mixture of hexane:ethyl 
acetate:methanol (5:5:2). Based on the lane spot pattern, fractions 1 – 34 were 
combined in to the E1 fraction, fractions 35 – 40 were combined into the E2 
fraction, fractions 61 – 100 were combined into the E5 fraction, and fractions 101 
– 120 were combined into the E6 fraction. 
B: Chromatographic fractions were checked by normal-phase thin layer 
chromatography (silica gel 60 F254) using a mixture of hexane:ethyl 
acetate:methanol (5:5:2). Fractions 41 – 50 were combined into the E3 fraction and 
fractions 51 – 60 were combined into the E4 fraction 
C: Thin layer chromatography (TLC) of E1 – E6 fractions of Q. phillyraeoides ethyl 
acetate extract. Chromatographic fractions were checked by normal-phase thin 
layer chromatography (silica gel 60 F254) using a mixture of hexane:ethyl 
acetate:methanol (5:5:2). The results for fractions E1 – E6 are shown. Among the 
fractions, E1 – E4 (Lanes 1 – 4) fractions showed clear spots and E5 – E6 (Lanes 
5 – 6) fractions did not show any spots 
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the spot patterns, as shown in Figs. 4.10A and 4.10B, six combined fractions were 
obtained as follows: E1 (Fr.1 – Fr.34), E2 (Fr.35 – Fr.40), E3 (Fr.41 – Fr.50), E4 (Fr.51 
– Fr.60), E5 (Fr.61 – Fr.100), and E6 (Fr.101 – Fr.120). Figure 4.10C shows the final 
TLC patterns of E1 – E6. Among these, E1 – E4 fractions showed clear spots and E5 – 
E6 fractions did not show any spots. These fractions were examined for α-glucosidase 
inhibitory activities, and showed IC50 values of 3 μg/ml (E1), 14 μg/ml (E2), 16 μg/ml 
(B3), and 35 μg/ml (E4) (Table 4.6). E5 and E6 fractions showed no inhibitory activity 
(Table 4.6). The fractions E1 – E4 showed excellent inhibitory effects on α-glucosidase 
activity, with E1 showing the strongest inhibitory effect (IC50: 3 μg/ml).  
Finally, ethyl acetate extract of Q. phillyraeoides (2000 g) was combined into 
six fractions with weights of 910 mg (E1), 30 mg (E2), 9 mg (E3), 130 mg (E4), 148 mg 
(E5), and 174 mg (E6) (Fig. 4.9). Three active fractions (E1, E2, and E4) were examined 
to purify the active compounds for inhibition against α-glucosidase according to the 
method described in Fig. 4.9. Although E3 fraction (9 mg) also showed high inhibitory 
activity, the amount of extract was not sufficient for further purification.  
E1 fraction was fragmented by MPLC (120 fractions). For primary 
investigation, every five consecutive fractions were checked from 120 fractions (1-5-10-
15------120, this way). According to the spot pattern, 120 fractions were combined as 
follows: E1-1 (Fr.1 – Fr.55), E1-2 (Fr.56 – Fr.74), E1-3 (Fr.75 – Fr.90), E1-4 (Fr.91 – 
Fr.104), and E1-5 (Fr.105 – Fr.120) (data not shown). The E1-1 – E1-5 fractions were 
checked by TLC using a mixture of hexane:ethyl acetate:methanol (5:5:2) (Fig. 4.11A) 
and ethyl acetate:methanol (5:1) (Fig. 4.11B). Among the fractions, E1-1 fraction showed 
a large spot, but the spot did not move. Therefore, it was not possible to determine whether 
this spot contained one or more molecules. E1-2 and E1-3 fractions showed spots but 
their patterns were not clear. E1-4 and E1-5 fractions did not show any spots (Fig. 4.11A). 
 Table 4.6 Inhibitory effects of E1 – E5 fractions of Quercus 
phillyraeoides ethyl acetate extract against yeast α-
glucosidase. 
 
 Fraction IC50  µg/ml  
 E1 3  
 E2 14   
 E3 16  
 E4 35   
 E5 NA   
 E6 NA   
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The E1-1 fraction showed a dark black spot, which moved but did not separate. Therefore, 
it was not possible to determine whether this spot contained one or more molecules (Fig. 
4.11B). E1-2 and E1-3 fractions showed smears (Fig. 4.11B). These fractions were 
examined for α-glucosidase inhibitory activities, and showed IC50 values of 3 μg/ml (E1-
1), 7 μg/ml (E1-2), 9 μg/ml (E1-3), 9 μg/ml (E1-4), and 11 μg/ml (E1-5) (Table 4.7). E1-
1 fraction showed the strongest inhibitory effect against yeast α-glucosidase with an IC50 
value of 3 µg/ml. The E1-1 fraction was again subjected to silica gel column 
chromatography, and each resulting fraction was checked by TLC. According to the spot 
 
Fig. 4.11 Thin layer chromatography (TLC) of E1-1 – E1-5 fractions of Q. 
phillyraeoides ethyl acetate extract. 
A: Chromatographic fractions were checked by normal-phase thin layer 
chromatography (silica gel 60 F254) using a mixture of hexane:ethyl 
acetate:methanol (5:5:2). Among the fractions, E1-1 fraction showed a large spot. 
E1-2 (Lane 2) and E1-3 (Lane 3) showed smeared spots, and E1-4 (Lane 4) and 
E1-5 (Lane 5) fractions did not show any spots.  
B: Chromatographic fractions were checked by normal-phase thin layer 
chromatography (silica gel 60 F254) using a mixture of ethyl acetate:methanol (5:1). 
The E1-1(Lane 1) spot was dark black, while E1-2 (Lane 2) and E1-3 (Lane 3) 
fractions showed smeared spots. 
 
 Table 4.7 Inhibitory effects of E1-1 – E1-5 fractions from E1 
fraction of Quercus phillyraeoides ethyl acetate 
extract against yeast α-glucosidase. 
 
 Fraction IC50  µg/ml  
 E1-1 3  
 E1-2 7   
 E1-3 9  
 E1-4 9   
 E1-5 11   
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pattern, four fractions were combined as follows: E1-1-1 (Fr.1 – Fr.3), E1-1-2 (Fr.4 – 
Fr.5), E1-1-3 (Fr.6 – Fr.7), and E1-1-4 (Fr.8 – Fr.19) (Fig. 4.12A). These four fractions 
were checked by TLC (Fig. 4.12B). Among them, the E1-1-1 fraction showed a dark spot. 
E1-1-2 and E1-1-3 fractions showed smeared spots and E1-1-4 showed no spots. These 
fractions were examined for α-glucosidase inhibitory activities, and showed IC50 values 
of 6 μg/ml (E1-1-1), 21 μg/ml (E1-1-2), and 30 μg/ml (E1-1-3) (Table 4.8). E1-1-4 
fraction showed no inhibitory effect on α-glucosidase (Table 4.8). E1-1-1 fraction showed 
the strongest inhibitory effect on yeast α-glucosidase with an IC50 value of 6 µg/ml. The 
E1-1-1 fraction was further purified by HPLC to provide the E1-1-1-1 fraction (QPE-1), 
which was collected at a retention time of around 8 (I) minutes as determined by UV 
 
Fig. 4.12 Thin layer chromatography (TLC) of E1-1 fraction of Q. phillyraeoides 
ethyl acetate extract. Chromatographic fractions were checked by normal-phase thin 
layer chromatography (silica gel 60 F254) using a mixture of ethyl 
acetate:methanol:water (8:2:1). 
A: According to the spot pattern, fractions 1 – 19 were combined as follows: E1-1-1 
(Lanes 1 – 3), E1-1-2 (Lanes 4 – 5), E1-1-3 (Lanes 6 – 7), and E1-1-4 (Lanes 8 – 
19).  
B: Combined fractions were checked by TLC. E1-1-1 (Lane 1) fraction showed a dark 
spot, E1-1-2 (Lane 2) and E1-1-3 (Lane 3) fractions showed smeared spots, and 
E1-1-4 (Lane 4) showed no spot. 
 
 Table 4.8 Inhibitory effects of E1-1-1 – E1-1-4 fractions from 
E1-1 fraction of Quercus phillyraeoides ethyl acetate 
extract against yeast α-glucosidase. 
 
 Fraction IC50  µg/ml  
 E1-1-1 6  
 E1-1-2 21  
 E1-1-3 30  
 E1-1-4 NA   
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monitoring at 210 nm (Fig. 4.13). The purified fraction was also checked by TLC and 
showed a clear spot (Fig. 4.14). The E1-1-1-1 (QPE-1) fraction showed a strong inhibitory 
effect with an IC50 value of 1.6 µg/ml (Table 4.9).  
The E2 fraction was divided into two fractions (E2-1 and E2-2) by HPLC, and 
an individual peak was found in fraction E2-1 collected at a retention time of around 8 (I) 
 Table 4.9 Inhibitory effects of E1-1-1-1 fraction from E1-1-1 
fraction of Quercus phillyraeoides ethyl acetate 
extract against yeast α-glucosidase. 
 
 Fraction IC50  µg/ml  
 E1-1-1-1 (QPE-1) 1.6  
 
Fig. 4.13 High-performance liquid chromatography (HPLC) of E1-1-1 fraction of Q. 
phillyraeoides ethyl acetate extract. A peak was found at a retention time of around 
8 (I) minutes by UV monitoring at 210 nm. 
 
 
Fig. 4.14 Thin layer chromatography (TLC) of E1-1-1-1fraction of Q. phillyraeoides 
ethyl acetate extract. Chromatographic fractions were checked by normal-phase thin 
layer chromatography (silica gel 60 F254) using a mixture of hexane:ethyl 
acetate:methanol (8:2:1). Purified fraction E1-1-1-1 (QPE-1) showed a clear spot. 
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minute as determined by UV monitoring at 210 nm (Fig. 4.15). The purified fraction was 
also checked by TLC and showed a clear spot (Fig. 4.16). The E2-1 (QPE-2) fraction 
showed significant inhibitory activity with an IC50 value of 26 μg/ml (Table 4.10). 
 
Fig. 4.15 High-performance liquid chromatography (HPLC) of E2 fraction of Q. 
phillyraeoides ethyl acetate extract. Peaks were found at retention times of about 8 
(I, E2-1) and 16 (II, E2-2) minutes by UV monitoring at 210 nm. 
 
Fig. 4.16 Thin layer chromatography (TLC) of E2-1fraction of Q. phillyraeoides 
ethyl acetate extract. Chromatographic fractions were checked by normal-phase thin 
layer chromatography (silica gel 60 F254) using a mixture of hexane:ethyl 
acetate:methanol (5:5:2). Purified fraction E2-1 (QPE-2) showed a clear spot. 
 
 Table 4.10 Inhibitory effects of E2-1 and E2-2 fractions from E2 
fraction of Quercus phillyraeoides ethyl acetate 
extract against yeast α-glucosidase. 
 
 Fraction IC50  µg/ml  
 E2-1 (QPE-2) 26  
 E2-2 NA  
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The E4 fraction was fragmented by HPLC and showed four peaks (E4-1 – E4-
4) (Fig. 4.17). These four fractions were checked by TLC (Fig. 4.18). The E4-2 fraction 
showed a clear spot, E4-1 and E4-3 fractions showed faint spots, and E4-4 fraction 
showed no spots (Fig. 4.18). These fractions were examined for α-glucosidase inhibitory 
activities, and showed IC50 values of 55 μg/ml (E4 1) and 73 μg/ml (E4-2). E4-3 and E4-
4 fractions showed no inhibitory effect on α-glucosidase activity (Table 4.11). The E4-2 
fraction was purified by HPLC and fragmented into three fractions (E4-2-1 – E4-2-3), 
 
Fig. 4.17 High-performance liquid chromatography (HPLC) of E4 fraction of Q. 
phillyraeoides ethyl acetate extract. Four peaks were found in fraction E4 by UV 
monitoring at 210 nm 
 
 
 
Fig. 4.18 Thin layer chromatography (TLC) of E4 fraction of Q. phillyraeoides ethyl 
acetate extract. Chromatographic fractions were checked by normal-phase thin layer 
chromatography (silica gel 60 F254) using a mixture of hexane:ethyl acetate:methanol 
(5:5:2). E4-2 (Lane 2) fraction showed a clear spot, E4-1 (Lane-1) and E4-3 (Lane 3) 
fractions showed weak spots, and E4-4 showed no spots. 
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which were collected at retention times of around 18 (I), 29 (II), and 31 (III) minutes as 
determined by UV monitoring at 210 nm (Fig. 4.19). Among them, the E4-2-1 fraction 
showed a clear peak. These fractions were examined for α-glucosidase inhibitory 
activities, and showed IC50 values of 27 µg/ml (E4-2-1), 33 µg/ml (E4-2-2), and 37 µg/ml 
(E4-2-3) (Table 4.12). The E4-2-1 (QPE-3) fraction showed strong inhibitory activity 
with an IC50 value of 27 µg/ml (Table 4.12).  
  
 Table 4.11 Inhibitory effects of E4-1 – E4-4 fractions from E4 
fraction of Quercus phillyraeoides ethyl acetate 
extract against yeast α-glucosidase. 
 
 Fraction IC50  µg/ml  
 E4-1 55  
 E4-2 73  
 E4-3 NA  
 E4-4 NA   
 
Fig. 4.19 High-performance liquid chromatography (HPLC) of E4-2 fraction of Q. 
phillyraeoides ethyl acetate extract. Three peaks were found in fraction E4-2 by UV 
monitoring at 210 nm. E4-2-1(I) fraction displayed a clear peak. 
 
 Table 4.12 Inhibitory effects of E4-2-1 – E4-2-3 fractions from 
E4-2 fraction of Quercus phillyraeoides ethyl acetate 
extract against yeast α-glucosidase. 
 
 Fraction IC50  µg/ml  
 E4-2-1 (QPE-3) 27  
 E4-2-2 33  
 E4-2-3 37  
 
60 
 
4.4 Discussion 
4.4.1 T. chebula 
The butanol extract of T. chebula showed high yeast α-glucosidase inhibitory 
activity in the screening experiments. The butanol extract was fractionated into seven 
fractions (B1 – B7) by silica gel column chromatography. Among them, the B1 fraction 
showed the strongest inhibitory activity. On HPLC, the B1 fraction showed two active 
peaks, designated as B1-1 (TCB-1) and B1-2 (TCB-2) (Fig. 4.1). B1-1 (TCB-1) and B1-
2 (TCB-2) fractions showed significant inhibitory effects against α-glucosidase, with IC50 
values of 2 μg/ml and 3 μg/ml, respectively (Table 4.2).  
T. chebula contains various phytoconstituents, such as alkaloids, flavonoids, 
glycosides, phenolic compounds, saponins, steroids, tannins, and quinine (Baliah and 
Astalakshmi, 2014). These active constituents have been applied as α-glucosidase 
inhibitors in many previous studies. Alagesan et al. (2012) reported that phenolic 
compounds of plants inhibited α-glucosidase enzyme activity. The results of the present 
study suggested that isolated fractions of T. chebula may contain compounds with α-
glucosidase inhibitory activities. 
4.4.2 M. japonicus 
The butanol extract of M. japonicus showed high yeast α-glucosidase inhibitory 
activity in the screening experiments. The butanol extract was fractionated into seven 
fractions (B1 – B7) by silica gel column chromatography, among which the B2 fraction 
showed the highest inhibitory activity. On MPLC, the B2 fraction was divided into five 
fractions (B2-1 – B2-5), and HPLC of the B2-4 fraction showed an active peak with an 
IC50 value of 10 μg/ml (B2-4-2; MJB 1). Li et al. (2009) reported that the flavonoids 
extracted from Crataegus monogyna (Hawthorn) leaves had an IC50 value of 7.1 μg/ml, 
and suggested that the extract contained the bioactive compounds, quercetin (flavonol) 
and vitexin (flavone) with α-glucosidase inhibitory activities. In the present study, the 
MJB-1 fraction isolated from M. japonicus showed an IC50 value of 10 μg/ml, which was 
close to that of the C. monogyna (Hawthorn) leaf flavonoid extract. This fraction may 
contain bioactive antihyperglycemic compounds. 
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4.4.3 Q. phillyraeoides 
The ethyl acetate extract of Q. phillyraeoides displayed the highest α-
glucosidase inhibitory activity in the screening experiments. The ethyl acetate fraction of 
Q. phillyraeoides was divided into six fractions by MPLC, among which the fractions E1 
– E4 shoed excellent inhibitory effects. Before purification, the E2 fraction showed higher 
inhibitory activity (IC50 value: 14 μg/ml, Table 4.6) than the E2-1 fraction (IC50 value: 26 
μg/ml, Table 4.10). These different inhibitory effects may have been because multiple 
components of the E2 fraction worked together, whereas the E2-1 fraction had a single 
component that worked alone. Repeated column chromatography of the ethyl acetate 
extract of Q. phillyraeoides (E1) fraction yielded E1-1-1-1 (QPE-1), which exhibited 
strong inhibitory activity (IC50: 1.6 µg/ml). On the other hand, Dewi et al. (2007) reported 
that the ethyl acetate extract of koji Aspergillus terreus fractionated by column 
chromatography and purified fraction F10-4 exhibited high inhibitory activity with an 
IC50 value of 2.9 µg/ml. These findings suggested that the α-glucosidase inhibitory 
activity of Q. phillyraeoides (E1-1-1-1) was stronger than that of koji Aspergillus terreus 
(Fr.10-4), which has been identified as a strong α-glucosidase inhibitor. 
Six fractions (TCB-1, TCB-2, MJB-1, QPE-1, QPE-2, and QPE-3) isolated 
from T. chebula (butanol), M. japonicus (butanol), and Q. phillyraeoides (ethyl acetate) 
leaf extracts were assayed for α-glucosidase inhibitory effects in vitro. Six isolated 
fractions exhibited strong inhibitory effects against α-glucosidase (Table 4.13). Wu et al. 
(2012) reported that six isoflavones, i.e., swertisin (119 μg/ml), 2"-O-rhamnosylswertisin 
(333 μg/ml), genistein (74 μg/ml), genistin (83 μg/ml), mangiferin (112 μg/ml), and 
daidzin (97 μg/ml), showed strong inhibitory effects against α-glucosidase activity, 
consistent with the results of the present study. 
Table 4.13 Effects of methanol extracts of the leaves of nineteen plants against yeast 
α-glucosidase 
Plant name Purified fractions IC50 (μg/ml) 
Terminalia chebula TCB-1 2 
 TCB-2 3 
Mallotus japonicus MJB-1 10 
Quercus phillyraeoides QPE-1 1.6 
 QPE-2 26 
 QPE-3 27 
Acarbose (Positive control)  13,000 
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We evaluated the inhibitory activities of six fractions (TCB-1, TCB-2, MJB-1, 
QPE-1, QPE-2, and QPE-3) against yeast α-glucosidase in comparison with the known 
α-glucosidase inhibitor, acarbose. All of the isolated fractions exhibited higher inhibitory 
activity than acarbose. Li et al. (2009) reported similar results where six compounds 
(apigenin, vitexin, isovitexin, luteolin, orientin, and isoorientin) showed stronger 
inhibitory effects than acarbose, which was compatible with the findings of the present 
study.  
  
 
63 
 
4.5 Conclusions 
Six fractions (TCB-1, TCB-2, MJB-1, QPE-1, QPE-2, and QPE-3) were 
isolated from T. chebula (butanol), M. japonicus (butanol), and Q. phillyraeoides (ethyl 
acetate) leaf extracts. Among these fractions, QPE-1, TCB-1, and TCB-2 exhibited 
excellent α-glucosidase inhibitory activities. The results of these experiments indicated 
that Q. phillyraeoides and T. chebula are candidates as sources of potential antidiabetic 
compounds. Further in vivo studies are necessary to confirm these observations. 
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Chapter 5 
General Discussion 
In Bangladesh, many medicinal plants are used to treat various types of disease. 
About 80% of the rural people are dependent on traditional medicine for their primary 
healthcare. However, very few plants are used to control diabetes. The rate of diabetes is 
increasing among people over 50 years old in Bangladesh, but the number of diabetes 
patients in Bangladesh is still not high. However, the number of patients with diabetes 
will likely increase in future because of the rapid growth of the Bangladeshi economy. 
Therefore, the new medicinal plants are required for the treatment of diabetes in 
Bangladesh. We screened the leaf extracts of three Bangladeshi medicinal plant species, 
i.e., E. officinalis, T. bellirica, and T. chebula, for antidiabetic effects. The results 
presented here confirmed that the leaf extracts of these three Bangladeshi medicinal plants 
showed significant inhibitory effects against carbohydrate digestive enzymes.  
Traditional medicine is occasionally used in Japan. In this study, 19 types of 
Japanese woody plant leaves were screened for carbohydrate digestive enzyme inhibitory 
effects, and to identify the structures of active constituents to produce modern medicines. 
Five plants, i.e., E. sylvestris var. ellipticus, M. japonicus, M. rubra, Q. phillyraeoides, 
and S. sebiferum, showed strong inhibitory effects against yeast α-glucosidase activity.  
Finally, the butanol extract of T. chebula, butanol extract of M. japonicus, and 
ethyl acetate of Q. phillyraeoides were examined to purify the carbohydrate digestive 
inhibitors. Six fractions (TCB-1, TCB-2, MJB-1, QPE-1, QPE-2, and QPE-3) were 
isolated from T. chebula (butanol extract), M. japonicus (butanol extract), and Q. 
phillyraeoides (ethyl acetate extract) leaf extracts. Among these fractions, QPE-1(Q. 
phillyraeoides), TCB-1 (T. chebula), and TCB-2 (T. chebula) exhibited excellent α-
glucosidase inhibitory activities. Based on the results of these studies, Q. phillyraeoides 
and T. chebula are candidates as possible sources of antidiabetic compounds. Further in 
vivo studies are necessary to confirm these observations.  
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